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The antipsychotic medications are recognized to be a crucial treatment for mental illnesses and 
frequently used in psychiatric settings. They are also recognized to produce a number of adverse 
effects that compromise a patient’s compliance and may lead to longer stay or re-admission. 
Nurses are in the best position to ensure medication management as they spend 24 hours at the 
bedside, administer and ensure patient surveillance. This role requires knowledge on 
psychopharmacology especially of the medication frequently used. However, literature 
highlights the lack of knowledge on psychopharmacology of nurses. 
This study therefore, aimed to assess nurses’ level of knowledge on antipsychotic medication, to 
determine nurses’ knowledge on antipsychotics’ health education and to determine 
characteristics associated to nurses’ knowledge on medication for nurses working in inpatient 
psychiatric hospital in Rwanda. Nursing management of drug therapy (Aschenbrenner and 
Venable, 2009:2) was used as theoretical framework. 
A non-experimental exploratory quantitative cross sectional survey design that is descriptive in 
nature was used to describe, firstly participants’ score and level of knowledge and secondly 
associations of demographic data and knowledge score. A convenient sample of 73 nurses was 
given an anonymous questionnaire. The population included nurses working in inpatient 
psychiatric hospital in Rwanda 
The mean score knowledge on therapeutic effects was 72.85±14.99;81.91±16.88  mean 
scoreknowledge on antipsychotic name; 38.61±12.38 mean score knowledge adverse effects; 
83.75±22.75 mean score knowledge on patient compliance monitoring and 74.54±32.52mean 
score knowledge on patient and family education practices. The overall mean score knowledge 
was 68.04 % ±11.53 and the majority of participants falls between 50- 74% (65.8%, n=48). 
There was no association of knowledge and experience, training and age. However, the 
association with qualification yield statistically significance (P-value=0.010). 
The results for this study suggest that nurses have medium knowledge on antipsychotic 
medication management. This study sustains the need for additional depth and breadth 
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1. Chapter one: Introduction 
1.1 Introduction and Background to the study 
 
Mental disorders continue to be a major public health problem worldwide. World Health 
Organisation (WHO, 2009:4) estimated that 450 million people worldwide were suffering from a 
mental health disorder, about 10% of adults were experiencing a mental health disorder and 25% 
was estimated to develop one at some point of time during their period of life. In all countries, 
developed and developing, all population, men and women at all stage of development, mental 
health problems can be found. In 2009 Mental health disorders were estimated to be 13% of 
global burden disease and projected to 15% by 2030 (WHO, 2009:2). 
It is reported that in low and middle-income countries approximately four out of five people are 
in need of mental health service but do not receive them. If offered, they are often not of high 
quality and interventions are not evidence based (WHO, 2010: 4). Schaal and Elbert (2006: 103) 
denoted that a large proportion of the Rwandan population is likely to experience durable mental 
health problems as a consequence of the Genocide. Schizophrenia and other psychotic disorders 
constitute the second cause of consultation (31.75%) after neurological disorders (38.5%) at 
Ndera hospital (Ministry of health, ((MOH), 2010: 143). Munyandamutsa and Mahoro  (2009) 
found that the prevalence of Post-Traumatic Stress Disorder in general, Rwandan population was 
estimated to be 28.54%. Literature highlights the presence of psychotic symptoms in people 
experiencing PTSD (Morrison et al., 2003: 335, Gaudiano and Zimmerman, 2010, Mueser et al., 
2010). 
In United States psychiatric illnesses have been found to be the cause of a large percentage of 
national in patient hospitalization. It is estimated that more than a quarter of all admission in 
hospitals are for psychiatric hospitalization (Rothschild et al., 2007: 160). Literature stresses that 
hospitalization in psychiatric hospital is linked to the nature of illness and the treatment received. 
The exploration of the relationship between duration of the first hospital admission and rate of 
readmission in psychiatric hospitals revealed that with long stay, patients have near total 
remission of symptoms, better insight into his illness, better follow up in treatment and 
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adequately performed psycho education (Vasudeva et al., 2009: 283). It was therefore indicative 
that long stay at the first admission would reduce readmission rate. 
In the treatment of inpatients with schizophrenia and other psychotic disorders, the antipsychotic 
drugs are globally recognized as a crucial component of treatment and it is mainly the nurses’ 
responsibility to administer those medications (Duxbury et al., 2010: 53). The effectiveness of 
antipsychotic drugs is irrefutable in reducing symptoms of psychotic diseases (Huang et al., 
2009:401). However, all groups of antipsychotic medication have shown to give moderate 
improvement in psychosocial functioning (Swart et al., 2007: 433) and require adjunction of 
psychosocial rehabilitative interventions (Swart et al., 2007:434, Uys and Middleton, 2004). 
Moreover, the side effects can also be hampering that they lead to poor adherence and setback 
and contributing to stigma and discrimination (Jones and Jones, 2008:50). 
Nowadays, the psychiatric treatment in term of pharmacology has improved with the 
development of new drugs which have shown to be extremely effective in managing many acute 
and chronic mental illnesses (Rothschild et al., 2007: 156).The meta-analysis study on new 
antipsychotics versus first generation has shown that many of new drugs are more efficacious 
than the  first generation drugs in the main domains (Leucht et al., 2009: 36). However, the 
literature underlined the effectiveness and cost effectiveness of some first generation drugs 
(perphenazine) over the new ones (Stroup and Liberman, 2010:57).  
In clinical practice antipsychotic drug choice depends mostly on adverse effect profile. The first 
generation antipsychotic has been associated with the lack of compliance due to extra pyramidal 
adverse effects (Jones et al., 2006 :26). However, it is stressed that the new generation of 
antipsychotics present life threatening metabolic side effects that may also hinder patient 
adherence to medication (Hodge and Jespersen, 2008:2). It is urged to regularly monitor 
effectiveness and safety issues related to adverse effects of antipsychotic medication in order to 
evaluate patient’s tolerability to medication and to promote patients’ compliance (Davies et al., 
2010:105). 
It is proved in literature that nurses are the cornerstone in medication administration not simply 
giving medication but more than procedural practice. People suffering from psychotic disorders 
do require interventions to help them take medication and nurses need the skills to communicate 
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with patients, observe and monitor the adverse effects in order to promote medication adaptation 
to their patients states. De Koning, Bloemen, Van Amelsvoort, Becker,Nieman, Van der Graag     
and Linszen  (2006:440) recommend strategies to improve adherence such as social support, 
psycho-education, family intervention and cognitive behavioural therapy. Medication 
management and concordance therapy is very relevant for patients in hospital, although the 
realities of implementation are sadly lacking to the detriment of patient care (Jones, 2006:4). 
Nurses are called to manipulate medication in their daily activities. This process is composed of 
many stages from storage, prescription, drug administration and drug monitoring and implies the 
accuracy and safety to patient. 
In many countries especially in Europe medication prescribing is included as a nursing role. In 
2003, nurse prescriber was accepted in United Kingdom and the curriculum was adapted to 
ensure that nurses have required competence (Skingsley et al., 2005: 990). In low income 
countries the nurse prescribing role is linked to shortage of medical staff and huge curative and 
preventive health care needs. The nurses in Botswana independently practice in primary health 
care and South Africa has regularized the nurse prescribing role with recommendation to  
additional training (Miles et al., 2006:293). The guidelines and regulations are stated in Nursing 
Act 33 section 56 (South African Nursing Council, 2005:39). In Rwanda nurses prescribe  
medication in primary health care but also in hospitals where there is a shortage of medical 
staff(Shumbusho et al., 2009: 2).Even though, nurses prescribe in low income countries, this is 
still considered as an exceptional situation to be implemented if doctors are not available (Miles 
et al., 2006:292). At Ndera Neuro-Psychiatric hospital, registered nurses are allowed to work in 
consultation and therefore prescribe in the absence of the doctor (Iyamuremye, 2011). However, 
they do not prescribe in the ward.  
In developed countries nurse prescribing role is coupled with innovation of new advanced 
nursing role (Miles et al., 2006: 291). According to Hughes (2010: 20)the mental health nurse 
prescribing role is a positive experience to nurses and patients and has shown its effectiveness in 
improvement of care. However, the qualitative study conducted by Jones (2006:9) exploring the 
relationship between nurses and psychiatrists in hospital psychiatric wards in regard to 
prescribing role revealed that the nurse prescribing role was considered as an exposure to 
negative outcomes as nurses were seen as lacking knowledge and competence to prescribe for 
4 
 
different disorders. Nakanishi, Koyama, Ito, Kurita and Higuchi, (2006: 202) underlined the 
collaboration between nurses and doctors about nurses’ involvement in medication management 
to improve patients ‘compliance. This collaboration helps to overcome the medication errors and 
side effects of those medications which continue to be a significant problem in managing people 
suffering from psychiatric disorders. 
A study conducted in the USA to evaluate medication safety in psychiatric hospitals, reported a 
high number of adverse effects associated with some errors which were preventable. Those 
errors occurred during ordering (68%) transcription (20%) and administration stage (10%) 
(Rothschild et al., 2007:160). Bademli and Buldukoglu (2009:360) explored oral medication 
management in Turkey and found out that nurses were not monitoring medication ; 26.1% of 
nurses do not feel the need to collect data on previous medication and others do not consider 
checking if patient has swallowed the tablets as an important part of medication management. 
It is known everywhere that psychiatric patients may refuse to take medication, refuse injection, 
hide the pills, reject or vomit swallowed pills and that may be challenging to a nurse who must 
give those medications. The medical errors in psychiatric hospitals in regard to pharmacotherapy 
may be associated with psychiatric patients; antipsychotic drugs and the psychiatric setting in 
that sense some patient may refuse to take their medications as well as lower ratios of nursing 
staff to patient and monitoring issues (Rothschild et al., 2007:161). 
While the nature of psychiatric illness is not easy to manage, the vulnerability of patients may 
add to that burden. A study conducted in Denmark of child and adolescent psychiatric use of 
antipsychotic medication showed that akathisia, tiredness, weight gain and Parkinsonism were 
adverse effects manifested in children and adolescents who receive the drugs(Deurell et al., 
2008:467). Sivaprasad, Hassan and Handy (2006:166) underlined that the new antipsychotic 
drugs cause more adverse effects to children and adolescent than in adults and those effects may 
be sedation, weight gain and liver function abnormalities. During pregnancy, antipsychotic 
medication may be associated with embryos or infant toxicity like cardiac, facial malformation, 
low birth weight babies and gestation impediments such as diabetes, polyhydramnios and 
others(Galbally et al., 2010:99). Literature highlights the complications associated with 
antipsychotic medications in elderly peoples. Antipsychotic drugs increases risk of falls 
associated with injuries undermines physical and psychological welfare which can hamper 
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rehabilitative process and can advance cognitive impairment for people with dementia (Hughes, 
2008:34). The randomized controlled trial study about antipsychotic medication and associated 
death in elderly Veterans revealed that  antipsychotic medication especially Haloperidol was 
associated with stroke, arrhythmias, thrombosis, aspiration pneumonia and thus increased 
mortality rate (Hollis et al., 2006:985). 
It is known that medication compliance is an essential component in management of mental 
health problems. The literature reviewed by Fernandez, Evans, Griffths and Mostacchi  
(2006:77) underlined that patient do not comply with medication when they lack knowledge, 
awareness and understanding of adverse effects. The non-adherence to antipsychotic medication 
delays the recovery process and hampers the management of mental illness as it is associated 
with multiple hospitalizations (Byrne et al., 2010:114). A study conducted in Nigeria exploring 
patient attitudes towards antipsychotic medication highlighted the association of side effects 
(extra pyramidal side effects) and negative attitudes such as poor compliance to medication as 
patients experiencing those adverse effects found drugs unpleasant and would like to stop 
medication especially those who are employed (Adewuya et al., 2006:210). Nevertheless,  
literature stresses that sometimes nurses do not perceive ensuring compliance and monitoring 
adverse events as an imperative part in their role (Bademli and Buldukoglu, 2009:360). 
Researchers have found medication administration time as an essential occasion for engaging 
with patient in therapeutic relationship as a good opportunity to listen and give information 
related to medication to patients. Thus the quality of relationship will determine patient attitudes 
and adherence to the treatment (Day, 2005, Duxbury et al., 2010) . Nurses’ skills in establishing 
interpersonal relationships, patient education and problem solving are essential to convince 
patients who refuse to take medication and to help them to adhere to the treatment plan 
(Fernandez et al. 2006;Bademli and Buldukoglu, 2009:360). According to Byrne et al. 
(2010:118) patients’ outcome is conditioned essential by professionals’ attitudes towards 
psychiatric medication . 
The role played by mental health nurses in supporting and advising patients to adherence 
strategies, comprises education to patient about medication benefits and adverse effects, self-
management with recognition of side effects (Fernandez et al., 2006:71). According to Kendall, 
Deacon-Crouch and Raymond (2007:173), one of the key functions of nurses is health education 
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and of the individual patient or a group of patient in order to promote and to maintain health. 
Health education is therefore a moral, legal and professional duty. Allowing patients to make 
informed choices and to feel respected is crucial regarding medication as it may permit 
adherence to medication and consciousness of the lifestyle changes that are necessary when 
taking antipsychotic drugs(Jones and Jones, 2008:50). 
A study conducted in Turkey, evaluating oral medication management found that nurses were 
lacking specific education on psychiatric nursing and that have a huge impact on patient care 
(Bademli & Buldukoglu,2009; Davis et al. 2010;Schellack, 2010:203). It is recommended that 
nurses should collaborate with other health care professionals in identifying high risk and 
inefficient work processes in order to ensure efficiency and safety of medications as outcomes of 
better management(Bennet et al., 2006:35). 
1.2 Problem statement 
 
Although medication management is sensibly well documented in developed and high income 
countries, there are limited studies about medication use in Rwanda. However, medicine 
management assessment has shown the mismanagement and lack of knowledge in the greater 
part of health professionals. USAID through his project called Management of Sciences for 
Health (MSH) assessed five general hospitals in Rwanda in regard to drugs management in order 
to establish a training module for health professionals. The assessment results highlighted 
excessive use of antibiotics, abuse of injections, inconsistency in prescription and  non-existence 
of a national plan to rationalize use of medicines (USAID, 2006:13). 
Nevertheless, the assessed hospital does not include Ndera Neuro Psychiatric hospital as the only 
psychiatric hospital managing the majority of antipsychotic medication in the country. Thus, 
there is little known knowledge about management of antipsychotic medication. Even though, 
the admission, treatment and hospital discharge have been objects of criticism, hospital care 
continues to be the keystone of psychiatric services. The medication of psychiatric illnesses can 
be prescribed for a long period and sometimes for the rest of a person’s life and that requires 
knowledge and experience, foundation of the development of health professionals’ skills to 
medication matters (Harris et al., 2009:113). 
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Nurses play a key role in medication management as they interact with patients administer, 
monitor their medication record information used to evaluate and improve patient outcomes 
(Byrne et al., 2010:115). However,  literature highlights the low level of autonomy for nurses 
and thus waiting for the doctors for decision making, for example, giving sedative injection in a 
critical case (Koukia et al., 2009:331). It is argued that adverse effects of antipsychotics are 
challenging for nurse managers due to diverse pressures on the services. Jordan, Jones and 
Sergeant (2009:182) stressed that nurses managers encounter various service demands and the 
monitoring of physical health for people with mental disorders may not be given the 
consideration it deserves.  
At Ndera Neuro-Psychiatric hospital, especially in acute wards , the side effects are present and 
patients are hospitalized within a short period after discharge (Ndera Neuro-Psychiatric hospital, 
2011:4). Literature reviewed in regard to the management of medication process as opposed to 
outcomes noted the relationship between professional lack of training in medication use and 
patient ‘manifestation of medication side effects (Maidment et al., 2006:412). As mentioned 
above, it seems there is lack of research conducted in Africa particularly in Rwanda to assess 
medication use particular antipsychotic medication. 
This study therefore focuses on nurses’ knowledge on psychotropic medication use, specifically 
antipsychotic medication, at Ndera Neuro psychiatric hospital to determine factors associated 
with nurses ‘knowledge. 
1.3 Purpose of study 
 
To explore nurses’ knowledge of medication management specific to antipsychotic medication 
and factors associated with knowledge.  
1.4 Research objectives 
 
1. Assess nurses’ level of knowledge on antipsychotic medication. 
2. Determine nurses’ knowledge on antipsychotics’ health education. 
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3. Determine characteristics associated to nurses’ knowledge on medication. 
1.5 Research questions 
 
1.1. What is nurses’ knowledge of antipsychotic medication therapeutic effects? 
1.2. What is nurses’ knowledge of typical and atypical antipsychotic medication risk and 
benefits? 
1.3. What is nurses’ knowledge of the benchmarked monitoring practices of a patient taking 
antipsychotic medication? 
1.4. Which characteristics associated with nurses’ knowledge on psychotic medications? 
1.6 Significance of the study 
 
Mental health and neurological disorders constitute 14% of global diseases burden and nearly 
three quarters of this burden take place in low and middle-income countries and the existing 
resources are scarce leading to treatment gaps of more than 75 % (WHO, 2010).In Rwanda the 
burden is suggested to be greater due to the Genocide and thus knowledge of psychotropic 
medication that reflects recommends best practice as essential to quality care. 
The findings of this study would add to the limited body of knowledge about the medication 
management in psychiatric patients in Rwanda. Since little is known about medication 
management in Rwanda, this study might serve as a basis for future pharmacological and nursing 
research in the area, thus increasing the comprehension of the issue and facilitating the 
development of treatment protocols. This will contribute to WHO initiative to improve quality of 
care rendered to individuals and families suffering from mental disorders. 
In Rwanda nurses are expanding their role to include medication prescription and management. 
Thus findings of this study might be used to assist nurses working in this setting to be aware of 
the knowledge gaps and identify training needs. The results of this study may also be used by the 
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nursing school to evaluate the knowledge gaps of their graduates and adapt a curriculum 
accordingly. 
The findings of this study may also help nurse managers at Ndera Neuro- Psychiatric hospital in 
planning training and management of antipsychotic medications.  The findings of this study may 
be used by the school of nursing to adjust and design the nursing curricula in regard to 
medication. 
The findings of this study might impact positively on clinical practice by increasing awareness of 
adverse events and strategies to monitor them. The promotion of best practices for patient safety 
may be results of this study. 
 It is therefore anticipated that the study findings will help in influencing the development of 
appropriate policies, standards, plans and intervention programmes for the management and 
treatment of psychiatric illnesses settings. This in turn, might improve the quality of care for 
people suffering from mental health disorders. 
1.7 Definition of concepts. 
1.7.1 Nurse: 
 
A nurse is a person who is especially prepared in the scientific basis of nursing and who meets 
certain prescribed standards of education and clinical competence to provide services that are 
essential to promote, to maintain and restore health and wellbeing (Dolrland, 2007).In this study 
the nurse will be every person who works at Ndera hospital, with nursing  education  recognized 
by the Rwandan nursing and midwives council. 
1.7.2 Knowledge: 
 
It is an understanding of information about a subject which a person get  by experience or study 
and which is either in a person’s mind or through general knowledge (Cambridge University, 




1.7.3 Antipsychotic medication: 
 
Medication used to treat the diagnoses of psychosis and severe behavioural problems (Dorland, 
2007:110). In this study the antipsychotic medication means all the medication used at Ndera 
hospital which meet international classification as antipsychotic medication. These medications 
are also called Neuroleptic medications or anti schizophrenic drugs (Schellack, 2010:102). 
1.7.3.1 Classical or typical antipsychotic: 
 
Typical antipsychotics (sometimes referred to as first generation antipsychotics) are the older 
medication used to treat psychotic symptoms(Purse, 2009). For this study, the classical 
antipsychotics used at Ndera Neuro-Psychiatric hospitals were explored. 
1.7.3.2 Atypical antipsychotic: 
Atypical (referred to as second generation) conveys simplistically the sense of antipsychotic that 
are different in some advantageous manner from conventional or typical agents (Grunder et al., 
2009:199). The object of this study explored knowledge of this group. 
1.7.5 Adverse effect: 
Adverse effect is defined as a harmful or abnormal result of medication. An adverse effect may 
be caused by administration of a medication or by exposure to a chemical and be indicated by an 
untoward result such as illness or death (McCreary and Jones, 2010:517). In this study adverse 
effect is related to extra pyramidal, metabolic, endocrinal, cardiac adverse events and other 
adverse events manifested by patients after administration of antipsychotic medication. 
1.7.6 Medication process: 
Medication process is defined as medication ordering transcription, dispensing, administration 
and discharge summaries (Lisby et al., 2005:16, Hertzum, 2010:648). For this study medication 
process means the nurses’ interventions in medication management including prescribing, 
administration, responding to and reporting adverse effects and therapeutic effects – psycho 
education and recording. 
11 
 
1.8 Conceptual framework 
 
The knowledge on medication framework by Aschenbrenner and Venable,(2009:2) shaped and 

















Figure1.1 Conceptual framework 
(Aschenbrenner and Venable, 2009:3). 
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The management of medication for people with mental illness, mental health nurses have a 
fundamental role. According to Duxbury et al., (2010:675) the nurse who administers medication 
must ensure the correct identity of a patient, correct medication, assess client conditions, 
effectiveness of medication and ensure patient surveillance. This assignment demand nurses to 
be knowledgeable about drug and patient status in order to maximize therapeutic effect of 
medication and to minimize the adverse effect with provision of education to family and patient 
(Aschenbrenner and Venable, 2009:2). 
Nurses use a specific body of drug knowledge in planning, implementing and evaluation of 
patients care. According to Aschenbrenner and Venable (2009:2) to ensure quality management 
of medication nurses must possess essential knowledge about medication and about patient 
personal history. 




Pharmacotherapeutics mean the desired, therapeutic effect of medication. Awareness of wanted 
therapeutic effect enables nurses to describe the effect of drug in patients and that help to 
determine the effectiveness of medication (Gutierrez and Queener, 2003:15). Therefore, the 
nurses must have cognitive understanding of the purpose of prescription or indication of 
medication given (Aschenbrenner and Venable, 2009:52). In this study, the nurses’ knowledge 
about different classification and indication of antipsychotic medication were explored. 
1.8.1.2 Pharmacokinetics 
 
Pharmacokinetics refers to the change that occur to the drug while it is inside the body 
Aschenbrenner and Venable(2009:41). The presence of medication in the body fluids or tissues 
in free or available form, determine its effectiveness but the medication have different abilities to 
produce an effect and to penetrate the site of action (Gutierrez and Queener, 2003:6). The 






Pharmacodynamics is defined as the study of physiological and biochemical interaction of drug 
molecules with the target tissue that is responsible for ultimate drug effects (Meyer and Quenzer, 
2005:21). According to Miyamoto, Duncan and Lieberman (2005:82), one antipsychotic 
medication may have multiple sites of action such as dopamine receptors, serotonin receptors, or 
others receptors with increased effectiveness on different symptoms or increased adverse effects. 
Aschenbrenner and Venable, (2009:41) urged that nurses must possess knowledge on how 
medication administered act on the patient’ body. The knowledge on the physiological, 
psychological and biochemical effect of medication were assessed in this study. 
1.8.1.4 Contraindications and precautions 
 
The management of medication requires being aware of conditions under which a given 
medication should not be given or must be administered with careful monitoring. Healey 
(2009:26) stressed on immense usefulness of antipsychotics medication. However, he urged for 
proper use considering their limitations in certain circumstances such as old age, and pregnancy. 
1.8.1.5 Adverse effects 
 
According to Clarke (2008:346), the detection and minimization of medication’ adverse effects 
will depend on mental health nurse ability to assess and give information on patients’ risk and 
development of adverse effects. The medication side effects may result in allergy or idiosyncratic 
response or organ toxicity. The introduction of medication into the body may on one hand cause 
the immune system response and that reaction engages the discharge of histamine with the 
allergic symptoms and on the other hand cause the strange effect opposing  the intended one 
(Aschenbrenner and Venable, (2009:55). This study explored nurses’ knowledge on 
identification and monitoring of adverse effects of antipsychotic medications. 
1.8.1.6 Drug interaction 
 
Antipsychotic medication may increase the action of other medications and vice versa, on the 
other hand the effectiveness of medication may be reduced in concomitance with other 
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medication (Gutierrez and Queener, 2003: 295). Thus medication interaction may be positive in 
that sense medication X increase therapeutic effect of medication Y or when it decreases the 
adverse effects. However, the interaction becomes negative when one medication decreases the 
effectiveness of others or potentiates the adverse effects (Aschenbrenner and Venable, (2009:58). 
1.8.2 Knowledge on patient variables 
 
The prescription and administration of medication imply the acquaintance of the person who will 
take this medication. This cognizance must go beyond patient identification with depth 
understanding on what brought him to seek care and what his/her historical background is. The 
awareness of history of present disease, health history and life span, cultural and social 
considerations is very crucial in medication initiation. The physical examination must be done in 
order to detect the untold medical problems (Gutierrez and Queener, 2003: 295, Aschenbrenner 
and Venable, 2009:52). 
1.9 Conclusion 
 
The aim of this chapter was to highlight the background to the problem of antipsychotic 
medication management in psychiatric hospitals. It was noted that antipsychotic medication are 
essential therapy in management of mental illnesses. However, their adverse effects may 
compromise the patients’ compliance. The nurses are in a better position to manage those 
medication issues and promote patients’ wellness and demand for knowledgeable and skilled 
enough in medication administration. The aim, objectives, research questions and conceptual 
framework have been presented and discussed. The conceptual framework highlighted that 
management of medication aim to reduce symptoms with maximization of therapeutic effects of 
drug, minimizing adverse effect and providing education to patients and   their families. 
However that requires knowledge on how medication work and patients’ state. This next section 




2. Chapter two: Literature review 
2.1 Introduction 
 
Antipsychotic medications have been a subject of study for different researchers. It is essential to 
review and compare the prior findings in order to explore gaps that need further research. This 
section reviews some of the current literature with respect to medication management in 
psychiatric nursing and its impact on medication outcomes. To search for the literature different 
on-line data base were used including MEDLINE-Ebscohost, MEDLINE-PubMed, CINAHL, 
Cochrane library, BioMED Central, Science direct, Africa wide info , LWW Journal @ OVID 
full text and the following search terms were used “antipsychotic medication and nurses”, 
“antipsychotic management in psychiatric hospital”, “nurses  knowledge and antipsychotic 
medication”, “antipsychotic medication outcomes”. 
2.2 Nurse’s pharmacological knowledge 
 
In their daily activities nurses manipulate the medication. They are thus required to possess the 
necessary knowledge and skills in pharmacology. It is evident that in drug therapy nurses are the 
backbone in the implementation and evaluation of outcomes, contributing to quality medication 
management (Bullock and Manias, 2002:14).  Nevertheless,  literature highlights nurses’ lack of 
knowledge in medication(Simonsen et al., 2011:9) such as prescribing (Sodha et al., 2002:313), 
administration (Lexshimi et al., 2009:21). 
2.2.1 Nurses educational preparation to their role. 
 
According to Trnobraski (1993 in King (2004:393) nursing profession strongly emphasize on 
caring rather than curing thus giving little importance on the medical model which only stresses 
on disease. In regard to medication management, the nurses’ uncertainty of their scope has been 
observed, even questioning if monitoring of adverse effects is  within their role (Dilles et al., 
2010:1076). Pharmacology is considered as biological science and it is revealed that in academic 
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processes, the biological sciences are branded as complicated by students and therefore are 
escaped or neglected (King, 2004:393). 
In a study by King (King, 2004:395),students reported  low levels of pharmacology knowledge 
attributed to low level of teaching. They highlighted little time, lack of course structure and 
insufficient content. Manias & Bullock (2002:15) stressed  the difficulties experienced by 
nursing students to transfer pharmacology knowledge into practice. The lack of emphasis on the 
accountability connected to medication administration has been a subject of criticism in nursing 
(King, 2004:396). 
Pharmacology knowledge is crucial in the performance of nursing role such as patient 
medication education. In their study Dilles et al (2010:1077) found  that nurses with high levels 
of education were more likely to recognize adverse effect of medication. However, there were no 
difference in providing information and observation of non-adherence between different levels of 
education. A study by Blegen,Vaugh& Goode (2001:36) found  that the nurses’ educational 
background  did not influence their ability to detect medication errors and patient falls. This is 
inconsistent with the results by Ndosi & Newell (2008:577) who found the difference in 
knowledge score according to education level with high score to nurses with postgraduate level. 
Literature highlights that continuous education is crucial to increase nurses’ knowledge of 
medication management (Carithers, 2011:38) and emphasized on the need to review nursing 
curriculum to increase basic knowledge of pharmacology (Bullock and Manias, 2002:13). 
2.2.2 Nurses knowledge of medication management 
 
Medication administration is a core nursing role and demands knowledge of drugs and the 
process (Lexshimi et al., 2009:18). The authors further explored nurses’ knowledge of 
medication administration and found  that nurses were knowledgeable of some elements of 
medication administration but were also lacked knowledge in other for example  drug action and 
different routes (Lexshimi et al., 2009:21). In a study by Ndosi & Newell (2007:576), nurses 
answered satisfactorily on medication dosage but inadequately on the mechanisms of action and 
drug interactions. According to Modic & Schoessler (2008:296) medication administration 
requires competencies that enable nurses to administer, monitor therapeutic and non-therapeutic 
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effects of medication and that it entails knowledge of indication, mechanisms of action, adverse 
effects and drug interactions. 
The findings of a study by King (2004:397), demonstrated that nurses were lacking in 
pharmacology understanding when they failed to give definition of familiar medications. 
However, they underlined medication administration, prescribing and patient education as their 
core role which requires pharmacology knowledge. In regard to antipsychotic medication, it was 
found that poor knowledge is coupled negatively with beliefs and attitudes with involvedness in 
promotion of patient adherence to the treatment (Byrne et al., 2005:517). 
In the UK, Fretwell & Felce (2007:584), explored community nurses’ knowledge of 
antipsychotic adverse effects and on half participants were aware of rational numbers of adverse 
effects while the other half were able to identify only three or less. Armstrong-Esther, Hagen, 
Smith & Snelgrove (2008:32) found  that a number of nurses were not able to recognize adverse 
effects, 25% to 34.1% did not  know if the drug they manipulated was antipsychotic. However, 
the majority were able to recognize the importance of adjustment of dosage for old people. 
Nowadays, nursing role is expending and Hughes (2010:19) argued for improved pharmacology 
education and continuous professional development in order to gain depth and breadth 
knowledge on how medication work inside the body and how adverse effect are produced. 
Therefore, the process of medication management requires nurses to be equipped with 
professional judgment, critical thinking skills underpinned by pharmacological skills (Brady et 
al., 2009:692). Clarke (2008:347) argues that antipsychotic medication management entails 
knowledge of mechanism of action and adverse effects. 
2.3Antipsychotic medication 
 
Antipsychotic medications are the pillars in managing schizophrenia and other psychotic 
disorders. The antipsychotic medications have shown their effectiveness in the improvement of 
positive symptoms of schizophrenia. Taylor et al. (2005 in Clarke, 2008:334) stressed that the 
therapeutic effect is observed in 80% of people living with schizophrenia with prescription of 
antipsychotic medication. However, those medications may give a little improvement; 
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deteriorating patient state or cause a wide range of treatment related adverse events (Nyhuis et 
al., 2010:1). Even though, classical antipsychotics treat the positive symptoms decreasing hyper 
dopaminergic state, its occupation on striatal D2 receptors is responsible of extra pyramidal 
adverse events (McCreary and Jones, 2010:516). Atypical antipsychotics are known to have a 
great action on psychotic symptoms as they treat also negative symptoms of schizophrenia 
(Davies et al., 2010:98) underlined that second generation of antipsychotic has interaction with 
different neurotransmitters and has shown its effectiveness in the management of acute and long-
term schizophrenia and mood disorders. Nevertheless, some patients experience adverse events 
and for others there is no full response to their state. The management of antipsychotic 
medication therefore demand active surveillance and appropriate choice of medication in regard 
to patient attribute and response. 
Adewuya et al. (2006:210) conducted a cohort study exploring attitude of people living with 
schizophrenia towards antipsychotic medication and found out that extra pyramidal side effects 
were strongly associated with negative attitudes. A study exploring the prevalence of Clozapine 
side effects has found that 100% of respondents experienced adverse events, 74% reported a 
drooling mouth at night, 41% weight gain and others reported urinary problems, sedation and 
constipation. The prescription of antipsychotic medication must take into account the 
vulnerability of individual patient. According to Laroche, Charmes, Nouaille, Fourrier and Merle 
(2006:57) the prescription of medication to elderly people oblige a cautious therapeutic choice 
regarding their weaknesses. Other studies emphasized on a thorough utilization of antipsychotic 
medication in children, and pregnant women (McCauley-Elsom and Kulkarni, 2007:290, Gilbert, 
2009, Galbally et al., 2010).Considering the risk and benefits associated with antipsychotic 
medication, the strategies minimizing risk must be carefully implemented. 
2.3.1 Antipsychotic classification 
 
In 1952, chlorpromazine as a first antipsychotic was discovered; the discovery stimulated 
scientific effort with the development of other complex antipsychotic medications (Jindal and 
Keshavan, 2008:1048). Today, there are two classes of medication for psychosis: Typical 
antipsychotics or fist generation, atypical antipsychotics or second generation (White and Hardy, 
2010:394). Literature emphasizes on first and second generation comparing their actions and 
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effectiveness. McEvoy, Zigman and Margolese (2010:146) weighted the effectiveness of two 
classes, and stressed that there is no clear-cut differentiation; one must examine effectiveness in 
regard to clinical effects and cost effectiveness. Consequently, nurses’ involved in medication 
management should be aware of the different classes as well as their action in order to offer 
suitable nursing care. 
According to Leucht et al. (2009:35) first and second generation antipsychotics are subject of 
controversy in regard to attributed merits; their meta-analyses did not reveal an efficiency, 
compliance or health related quality of life significantly different in two groups. McEvoy, 
Zigman and Margolese (2010:145) detailed that first generation of antipsychotic act in blocking 
the receptors D2 with limited therapeutic effect in management of acute illness and prevention of 
relapse while the second generation act in blocking the receptor D2 and 5-HT2  reduce the risk 
of extra-pyramidal side effects. Adewuya et al. (2006:210) highlighted the lack of second 
generation in African countries where the first generation is still the first choice. At Ndera 
hospital the second generation is rarely available and not everyone can afford it. 
The table 1.1 Classification antipsychotic medications 
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2.3.2. Mechanism of action of antipsychotic medications 
 
Antipsychotic medications focus on chemical disturbances and act by influencing the process of 
neurotransmitters. They may interfere by blocking receptor site or activating receptor by 
attaching to a receptor site (Pandya, 2009:23). The excessive dopamine in synapses between 
brain cells in limbic zone is responsible of positive symptoms of psychosis while slight 
dopamine between synapses in cerebral cortex is theorized to be responsible for cognitive and 
negative symptoms of psychoses. The levels of noradrenalin and serotonin may be disturbed by 
dopamine deregulation resulting in affective and mood symptoms (White and Hardy, 2010:393). 
The mesolimbic area is responsible of positive feelings and pleasure as it is the emotional centre 
of the brain and the cerebral cortex that facilitates thinking, planning ahead as well as to acquire 
knowledge and behaviour (Jones and Jones, 2008:51). 
The classical and atypical antipsychotic medications block dopamine receptor in the brain and 
periphery. Horacek et al. (2006:390) urged that many of classical antipsychotics medication act 
essentially according to the affinities with specific receptors. Pandya (2009:24) showed the 
different receptor of Dopamine blocked by different antipsychotic medications including 
receptor D1, D2, D3 and D4. The binding of these medications tighter than dopamine to the D2 
receptors are responsible for extra pyramidal side effects such as acute dystonia, akathisia, 
Parkinsonism and tardive dyskinesia. 
The pharmacological action of atypical antipsychotics is exercised in inhibiting serotonin 
receptors 5-HT predominantly 5-HT2A. The blockage of 5-HT receptors is efficacy in reducing 
the negatives symptoms of schizophrenia. The action on different receptors including 5-HT1A,5-
HT2A,5-HT2C,5-HT6 and 5-HT7 is estimated  to express particular benefits effect to either the 
adverse effect profile or treatment of symptoms (McCreary and Jones, 2010:518).The atypical 
antipsychotics are reported to have affinity with a wide range of other neurotransmitters 
including adrenergic (alpha 1 and alpha 2),  histaminergic (H1and H2) and muscarinic ( M1,M2 
and M3),this action is called “magic shotgun”(Davies et al., 2010:98).The new generation of 




All antipsychotic medications can reduce the hallucination and delusions associated with 
psychosis (positive symptoms) by blockage of dopamine receptors in mesolimbic area of the 
brain. The negative symptoms are alleviated mainly by action of atypical antipsychotics on 
serotonin receptors. However all of those medications are responsible of adverse events due to 
their actions on different neurotransmitters (Davies et al. 2010:99). It is important to know how 
medication work and the wanted and unwanted effects in order to ensure proper management. 
The effect of medication inside the body is a process which is composed of different phases 
including absorption, distribution, metabolism and excretion. It was made clear that medication 
molecules move throughout the body during the different phases by passage into membranes, 
through membranes or liposolubility (Aschenbrenner and Venable, 2009:52). 
2.3.3 Antipsychotics adverse effects 
 
Evidence has proved effectiveness of antipsychotic medications in alleviating psychotic 
symptoms. Unfortunately, their occupation on the receptors is conveyed with neurological 
adverse effects. With classical antipsychotics motor side effects such as dystonia, tardive 
dyskinesia, akathisia and Parkinsonism tend to take place when about 80% of striatal D2 receptor 
sites are occupied. The action of atypical antipsychotics on multi-receptors is responsible of 
other side effect such as weight gains, dyslipidaemia, arrthymia and increased blood pressure 
(McCreary and Jones, 2010:516). Administering and monitoring medication are the core nursing 
role. However, in regard to antipsychotic use, nurses are challenged by management of that 
double edge sword problem of medications. Jones and Jones (2008:48) highlighted the dilemma 
faced by nurses who encounter stabilized patients but who report unpleasant side effects 
associated with medication. Hodge and Jespersen (2008:6)conducted a study comparing patients 
and clinicians views of clozapine’s side effects which revealed that the clinicians overestimated 
the prevalence of severity of clozapine’ side effects with inaccurate attribution of extra 
pyramidal adverse effects to clozapine. Many of these unwanted effects impact on patient 
compliance and affect the course of illness. Meyer and Quenzer (2005:453) report that non 
hospitalized patients stop taking medication because they are disturbed by the adverse effects 
with relapse of symptoms and rehospitalisation as a consequence. 
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2.3.3.1 Dopamine system adverse effects. 
 
The extra pyramidal side effects are mainly coupled with classical antipsychotics but can be 
observed with a higher dose of atypical antipsychotics (Pandya, 2009:24). The blockade of D2 
receptors in the niglostrial area is responsible of motor side effects such as tremors, restlessness, 
distorted postures and involuntary movements (Meyer and Quenzer, 2005:453). It is stressed that 
extra pyramidal symptoms are a source of discomfort; social stigma and therefore poor 
compliance (Muench and Hamer, 2010:618).These extra pyramidal side effects are classified in 
subtypes  below: 
2.3.3.1.1 Parkinsonism 
 
The Parkinsonism is most upsetting side effect of classical antipsychotics. The manifestation of it 
is mainly related to movement; including tremor, rigidity, bradykinesia and postural 
disturbances. They may also experience impairment of memory, abstract thinking and language 
as cognitive dysfunction (Meyer and Quenzer, 2005:126). These cognitive dysfunctions may be 
confusing in regard to diagnosis. The poverty of thoughts, akinesia, flattening affect, the loss of 
sense of pleasure, inability to pay attention associated with Parkinsonism may be confused with 
negative symptoms of schizophrenia or depression (Muench and Hamer, 2010:619) and that may 
make difficult the medication monitoring and patient follow up. The naturalistic study exploring 
the relationships between dosage and prescription of anti-parkinsonism revealed that the 
Parkinsonism symptoms were associated with important dosage of antipsychotics (Acquaviva et 
al., 2007:4). The reduction of dosage and oral anticholinergic drugs are used to treat 
Parkinsonism symptoms (Muench and Hamer, 2010:619, Pandya, 2009:24). The knowledge and 
understanding of Parkinson adverse effect will help nurse to educate patient on the risk benefit of 
medication as well as to effective prevention, control and management of different forms of that 
syndrome (Bulat et al., 2008:189). 
2.3.3.1.2 Dystonia 
 
The muscles’ spastic contractions are frequent with the antipsychotic treatment. They include 
torticolis, trismus, laryngospasm, oculogyric crisis, neck twisting and laboured breathing and 
facial distortion (Muench and Hamer, 2010:619, Pandya, 2009:25). The risk factors of dystonia 
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were highlighted in the literature, and took into account the male gender, young age less than 30 
years and the use of high potency antipsychotic medications. It is urged to treat those 
manifestations as they may cause discomfort as they can be life threatening 
2.3.3.1.3 Tardive dyskinesia 
 
The involuntary movements particularly of the face and jaw, purposeless, quick and uncontrolled 
movement of the arms and legs or slow squirming movement of the trunk, limbs and neck are the 
characteristics of tardive dyskinesia (Meyer and Quenzer, 2005:454).The abnormal movements 
can include myoclonic jerks, tics, chorea, dystonia which occur with long term antipsychotic 
treatment and may be irreversible even if medication is stopped (Muench and Hamer, 2010:620). 
The estimated incidence of tardive dyskinesia with overall antipsychotic is 10 to 20% and the 
incidence is increased to 50% in patients older than 60years and exceeds 70% in geriatric 
patients (Meyer and Quenzer, 2005:454). However, not only the old age, but in cases where there 
is presence of affective disorders, female gender, the neuroleptic exposure of more than 6 
months, history of Parkinson side effects, diabetes and high dosage of atypical agents are the risk 
factors of developing tardive dyskinesia (Khan et al., 2007:614) Tardive dyskinesia is treated by 
reducing antipsychotic dose to the minimum, substitution of old drugs by new ones and by 
reducing and discontinuing anticholinergic drugs (drugs used to lessen motors effect of 
antipsychotics) as they may exacerbate the symptoms of dyskinesia (Pandya, 2009:25). 
2.3.3.1.4 Akathisia 
 
The akathisia is manifested as an unpleasant feeling of inner restlessness demonstrated by a need 
to move and inability to sit still for any length of time. Akathisia occurs frequently in the first 
two weeks of the treatment and may be confused with anxiety and agitation. It can be controlled 
by reducing dose, using drugs with lower liability for akathisia or administering low dose of beta 
blocker (Pandya, 2009:25, Muench and Hamer, 2010:619). 
2.3.3.1.5 Hyperprolactnemia. 
 
The blockade of D2 receptors on pituitary gland stop the inhibition of prolactin discharge and 
therefore increase the plasmatic concentration of prolactin. The prolactin elevation above 600 ml 
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U/L is named hyperprolactnemia and the normal prolactin varies between 30-600 ml U/L. This 
elevation is the cause of many adverse effects including galactorrhoea, amenorrhoea, sexual 
dysfunction, gynecomastia and osteoporosis (Jones and Jones, 2008: 52). Literature highlights 
that all antipsychotic may be responsible of hyperprolactnemia and among others is the five 
medications which give more elevation, namely, sulpiride, risperidone, haloperidol, olanzapine 
and clozapine (Jindal and Keshavan, 2008:1050). 
Patients’ characteristics such as age and sex may exacerbate the increase of prolactin. It is 
highlighted in literature that women suffer more from prolactnemia than men due to the capacity 
of estrogens to augment serum prolactin level (Veselinovic et al., 2011:214). According to Jones 
and Jones (2008:23), the awareness to minor or high rises of prolactin by nurses is crucial in 
medication management as it enable nurses to inform patients about side effects associated with 
this elevation and that lead to medication adherence. 
2.3.3.2 Non dopamine adverse effects. 
 
The clinical antipsychotic trials of intervention effectiveness (CATIE) study was conducted in 
USA  and found  that metabolic disorder was more prevalent in people suffering from 
schizophrenia than in the general population and female were more vulnerable to  obesity 
(McEvoy et al., 2005:29). Patients experience weight gain, insulin resistance and elevation of 
non-HDL cholesterol and inflammatory markers when they are under Olanzapine, quetiapine and 
to a low degree risperidone with risk of diabetes mellitus and cardiovascular disease (McEvoy et 
al., 2010:145). 
2.3.3.2.1 Weight gain 
 
In psychiatric patients, weight gain is a common adverse effect and the average  weight of adult 
people with mental illness has been found to be expressively superior than that of people without 
mental illness (Correll and Carlson, 2006:777). Literature underlined the complexities of 
mechanisms weight gain of second generation antipsychotics. It is stressed that the sedation may 
reduce level of physical activities; augmentation of appetite is maybe related to the interaction of 
antipsychotics with dopamine, serotonin and histamine receptors (Werneke et al., 2002:145). 
Newcomer and Haupt (2006:464) reviewed literature related to metabolic adverse effect of 
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antipsychotics and found that the variability of weight gain according to the type of medication 
received and the duration of the treatment. Therefore the magnitude of weight gain was 
associated with long term treatment and some gained kilos ranged from 1kg to over 10kg per 
year. Many researchers highlighted other risk factors are associated with medication in 
generating weight for people living with mental illness. They stressed on poor diet, sedentary 
lifestyle and lack of access to medical care (Beebe, 2008:25, Kerna et al., 2009:21). Other studies 
have been conducted to explore the control and reduction of metabolic adverse effect and found 
that it was possible to minimize the antipsychotic medication induced weight gain. Chen, Chen& 
Huang(2009:21)conducted a one year follow up study for obese patients with schizophrenia and 
found a significant reduction of weight in the first ten week of weight control programme. This is 
confirmed by Poulin, Chaput, Simard, Vincent, Bernier, Gauthier,  et al. (2007:985) who 
maintain that promotion of  physical activity among people with severe mental illness has shown 
effectiveness in weight reduction and was most effective when associated with social support. 
2.3.3.2.2 Diabetes mellitus 
 
The new generation of antipsychotics are associated with the occurrence of diabetes mellitus in 
people treated with antipsychotic medications. The case control study showed that the risk of 
diabetes mellitus to people who received clozapine was 1.37 greater than people who has 
received conventional antipsychotics and 7.44 greater than people with no antipsychotic 
medications(Newcomer and Haupt, 2006:465). The review of twenty seven papers in regard to 
risk of diabetes with severe mental illness has been used to select nine studies used by Osborn, 
Wright, Levy, King, Deo and Nazareth (2008:5)in meta-analysis of diabetes and found  that risk 
ratio ranged from 1.21 to 2.27 and in regard to glucose levels there was a significant increase of 
standardized mean difference in the group of people with severe mental illnesses. A study by 
Van Winkel, De Hert, Van Eyck, Hanssens, Wampers, Scheen and Peuskens (2008:346) which 
assessed the  prevalence of diabetes in people with bipolar disorder, found  that the prevalence of 
diabetes were twice higher than in general population. However the risks were lower compared 







Literature highlights the association of Hyperlipidaemia with new generation of antipsychotic 
medications. Lambert, Chang, Tafesse and Carson (2005:15)conducted a case control study to 
examine the risk of hyperlipidaemia with antipsychotics. The cases were peoples who had been 
diagnosed with schizophrenia and have received one of antipsychotic 12 weeks before being 
diagnosed withhyperlipidaemia. The exposure to olanzapine was compared with exposure to old 
antipsychotic and odds ratio 1.20 and 95% CI 1.08-1.33 while clozapine versus old 
antipsychotics OR=1.16, 95% CI 0.99-1.37. However their study did not look at other factors 
that may be associated with hyperlipidaemia such as history of obesity in the family, smoking 
behaviour or dietary patterns. The results from many researches are consistent in regard to the 
association of hyperlipidaemia with clozapine and olanzapine. Clinicians especially the 
prescribers and nurses involved in drug monitoring must be aware of that risk and examine the 
efficacy, tolerability, and associated cost and safety concerns (Lambert et al., 2005:17). 
2.3.3.2.4 Cardiovascular effects 
 
The augmentation of the lipid levels are correlated to cardiovascular morbidity and mortality in 
people taking antipsychotic medications particularly new generation of antipsychotics. That adds 
to the risk associated with the life style of those peoples (Lambert et al., 2005:17). According to 
Kaponen, Alaraisanen, Saari, Pelkonen, Huikuri, Savolainen and Isohanni (2008:343), the 
polymorphic ventricular tachycardia is one of major cause of sudden death. They claimed that 
the antipsychotic medications are able to obstruct the rapid part of the rectifier potassium and 
cause long QT interval which is the alternative to polymorphic ventricular tachycardia. The news 
antipsychotics especially clozapine may cause an inflammation of the heart muscle that can be 
lethal and that emerge in the first few weeks of the treatment; cardiomyopathy may also be 
observed after months or years of treatment (Healey, 2009:40). Electrocardiography (ECG) is 





2.3.3.2.5 Anti-cholinergic effects. 
According to Healy (2009:38), certain antipsychotic medications such as olanzapine and 
chlorpromazine cause important anti-cholinergic effects. The patient under antipsychotic 
medication may present a dry month, nasal drying and blurred vision. Gallagher and Naidoo 
(2009:164) emphasized on the effects of medication on physiology of swallowing. They listed 
the side effects of psychiatric drugs impacting on swallowing including dry month or increased 
salivation which may lead to indigestion. A case reported by Suzuki, Ushida, Watanabe and 
Kasima (2007:525) showed that antipsychotic medications administered with anti-cholinergic 
medications may lead to severe constipation and paralytic ileus especially for old people. It is 
known that antipsychotic medications are prescribed to diminish agitation, inhibit delusion and 
hallucination. Nevertheless, anti-cholinergic effect of chlorpromazine may lead to agitation, 
confusion and hallucinations especially for old patients. According to Morrison, Meehan, 
Gaskill, Lunney and Collings (2000:815), the adverse effects reduction depends upon the ability 
of the case manager to assess and manage medication effects. The authors also highlighted the 
importance of sufficient training on psychopharmacology and up to date assessment practice as 
well as assessment and management of side effects. 
2.3.3.2.6 Sedation and arousal 
 
According to Sadock and Sadock, (2007:490), sedation and postural hypotension may be 
important adverse effects for patients who are receiving some medication such as perphenazine, 
and the severity of these symptoms may be observed with initial dose of medications. Taylor 
(2009: s16) reviewed post long acting injection adverse effects and observed the post injection 
syndrome which consist of sedation, confusion, dizziness, altered speech, somnolence and 
unconsciousness. Healy (2009:39) stated that the sedation effect may vary from individual to 
individual and from medication to medication. Thus, the same dosage for different individuals 
may give different results with sleeplessness for one and sedation for another. 
Townsend(2003:305) urged that nurses should discuss with the physician on the modality of 
treatment and instruct the client not to drive while experiencing sedation. Unwanted somnolence 
is managed by adjusting dosage or time for administration or gives another medication (Sadock 
and Sadock, 2007:982). 
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2.3.3.2.7 Skin effects 
 
Skin rashes may be caused by antipsychotic medications, all medication may engender those 
allergic reactions and lead to pronounced reactions necessitating to stop medication (Healey, 
2009:39). Skin reaction may be serious with the lacerations above the neck and may be 
accompanied by hyperthermia and lymphadenopathy necessitating the emergency treatment. 
With the classical antipsychotics a patient may experience an urticarial, maculopapular, petechial 
occurring early in treatment (Sadock and Sadock, 2007:983). 
The photosensitivity is also observed with antipsychotic medications and that individuals 
suffering from it may be burned when exposed to  sunlight for a given time (Healy, 2009; 
39).The chlorpromazine is associated with blue-grey discoloration of skin if administered for a 
long period while thioridazine is associated with retinal pigmentation with the high dosage 
(Sadock and Sadock, 2007:1049). The presence of the adverse effects implies the adjustment of 
dosage or discontinuation of medication. It is urged that patientshould wear sunglasses and not 
avoid exposure to sunlight for a long period (Sadock and Sadock, 2007:1049, Townsend, 
2003:306). 
2.3.3.2.8 Others adverse effects 
 
Agranulocytosis is recognized as a critical adverse effect caused by clozapine which is 
characterised by the decrease of white blood cells at a low level. It is recommended that the 
blood level of the individual on clozapine be monitored weekly and that the treatment must be 
discontinued if white blood cells are below 1500 mm3 (Townsend, 2003:307). Other hematologic 
adverse effects such as thrombocytopenic, haemolytic anaemia, pancytopenia may be observed 
(Sadock and Sadock, 2007:1048). 
The most occurring adverse effect is orthostatic hypotension especially with chlorpromazine, 
thioridazine and chlorprothixene. The orthostatic hypotension may cause falls and injuries. The 
management of hypotension demands to regularly monitor patient’ blood pressure and to advice 




2.3.3.3 Syndrome malignant of antipsychotics 
 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) cited by Neuhut, 
Lindenmayer&Silva (2009:415) describe neuroleptic malignant syndrome as a life threatening 
adverse effect of antipsychotic medication characterised by severe muscle rigidity, hyperthermia 
accompanied by two or more of the subsequent symptoms: diaphoresis, dysphagia, tremor, 
incontinence, tachycardia, alteration of blood pressure, alteration of consciousness from 
confusion, coma and mutism and leucocytosis. The sympatho-adrenal hyperactivity and defect of 
calcium explain the signs and symptoms on peripheral skeletal muscle system. Researchers have 
highlighted the necessity of a thorough differential diagnosis (Neuhut et al., 2009:415, Strauw et 
al., 2007:871, Berman, 2011:43). The authors stressed that special attention should be paid to the 
assessment of cerebro-neuronal system infections such as viral encephalitis, meningeal signs and 
other disorders such as heart stroke. 
The prognosis of Neuroleptic malignant syndrome has improved from 30% of mortality rates and 
closer to 10%. The recognition and treatment of symptoms at early stage offer a complete 
recovery in 2 to 14 days. The complications such as residual catatonia, Parkinson, renal and 
cardiopulmonary morbidity has been observed with delayed diagnosis (Berman, 2011:45). Seitz 
and Gill (2009:13) urged the discontinuation of medication, adequate care aimed to maintain 
hydration, renal functioning and temperature regulation. They underlined the role of medication 
management in prevention of that syndrome and remind clinicians to be aware of the risk 
associated with neuroleptic malignant syndrome and to monitor for this adverse effect. 
The nursing knowledge and understanding of client medical conditions, the medication 
effectiveness and adverse effects is essential to improve clients ‘physical and/or mental health. 
The adverse events of antipsychotic medication if not well managed may compromise the 
patient’s life. Correll (2008:196) underlined that, nurses and other professionals must have 
sufficient knowledge on antipsychotic management in order to ensure physical and psychological 





2.3.5 Contraindications, precautions 
 
The antipsychotic medications should not be given to patients with known hyper-sensitivity, 
Parkinson disease, liver, renal or cardiac insufficiency. They are also contraindicated in patients 
with central nervous system depression (Townsend, 2003:304). The clinicians must carefully use 
the antipsychotic medications during pregnancy due to their effects to an unborn baby. The 
mothers on antipsychotic medications are advised to avoid breastfeeding in order to prevent 
infant absorption of antipsychotics and thus adverse effects (Healey, 2009:25). In the elderly 
people, diabetic clients, and the severely ill and in respiratory insufficient patients it is 
recommended that caution should be given when administering the antipsychotic medication.2.4. 
Antipsychotic management for special conditions 
2.4.1 Antipsychotic medication and pregnancy 
 
The management of psychiatric illness has double challenges, on one hand the antipsychotic 
medications may be toxic and teratogen with long term neurobehavioral problems, while on the 
other hand the untreated illness may result in self-harm, suicide and neglecting of pre and post-
natal care (Menon, 2008:2). Therefore, the antipsychotic medications must be prescribed with 
regard to safety of managing them upon foetal growth and maternal health (Sit et al., 2006:362). 
The exposure to atypical antipsychotics for pregnant women is responsible for low birth weight 
and the baby born may experience foetal distress (Sit et al., 2006:363, McCauley-Elsom and 
Kulkarni, 2007, Galbally et al., 2010). The results of a retrospective cohort study from January, 
1993 to December, 2007 exploring all obstetrical deliveries showed that with atypical 
antipsychotic, the gestational age was shortened resulting to prematurity, heart murmurs and 
feeding difficulties (Wichman, 2009:53). A study by Sit, Rothschild and Wisner (2006:364) 
highlighted that the prescription of olanzapine during pregnancy may cause stillbirth at 37 
weeks, premature ruptured membranes, gestational diabetes and thrombocytopenia. The 
preeclampsia, elevated liver transaminases and hypothyroidism have been observed in women 
medicated with Olanzapine for all three semesters. Galbally et al. (2010:105) urged that 
medication monitoring during pregnancy must include the need to increase foetal growth, 
glucose test in order to detect the diabetes that may be associated with medication.  
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In patients with schizophrenia, the increased risk of cardiovascular congenital anomalies, low 
birth weight, may be associated with multiple risk factors such as nutritional status, smoking, 
alcohol use, physical and other pregnancy-related influences (McCauley-Elsom and Kulkarni, 
2007:291). The foetal effects of antipsychotic medication are explained by the capability of those 
medications to go by the placenta and entry into foetal brain and immature metabolic system to 
excrete the medication (Kulkarni et al., 2008:40) and the infant risk is due to the passage of 
antipsychotic medications by maternal milk (McCauley-Elson  et al., 2010:101, Einarson, 
2010:35). 
To take care of neonatal complication women should be advised to deliver in adequate health 
centres with neonatal resuscitation services. The baby born may experience the extra-pyramidal 
adverse effects that need a thorough surveillance (Galbally et al., 2010:106). The health 
professionals must ensure that care is provided to the patients and their families and that the risk 
factors for mothers and children are identified and reduced. There is a need to balance the risk to 
baby and risk of relapse for the woman during pregnancy and post-partum and that create 
problems and concerns about use of medication (McCauley-Elsom and Kulkarni, 2007:290). 
The experience of mental illness for women is accompanied by limited relationships, loss of jobs 
and separation of parents from their children. There is the high occurrence of unwanted 
pregnancies that are difficult to manage for women as well as for health workers (McCauley-
Elsom and Kulkarni, 2007:291). The post-partum period is accompanied by exacerbation of 
symptoms such as suicidal, infanticide ideas and hospitalization resulting in the new born being  
cared for by others (Gilbert, 2009:20). It is urged that the post-partum period must have an 
obvious management plan with regular assessment of mental status, treatment and social support. 
The support from husband and family is of great value in planning discharge as it underpins the 
mother-infant and family relationships (Galbally et al., 2010:106). 
2.4.2 Antipsychotic medication in elderly people 
 
The choice of appropriate medications to elderly people is complex and challenged by a number 
of characteristics related to age. Spinewine (2007:173) reports that increased disability, illnesses, 
and unpredictability of health status of the elderly people complicate decision making with 
regards to medications. Panula, Puustinen, Jaatinen, Vahlberg, Aarnio and Kivela (2009:968) 
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highlighted that the elderly peoples’ blood-brain barrier has an increased permeability which 
make easy the entrance of antipsychotic medications into the brain. 
To that vulnerability, the adverse effects of antipsychotic medications become challenging in 
managing the psychiatric disorders for people with advanced age. Knol, Van Marum, Jansen, 
Souverin, Schobben, and Egberts (2008:664) stressed that swallowing disorders are the cause of 
aspiration which is important in pathogenic mechanism of pneumonia. Consequently, the risk to 
acquire pneumonia is increased in elderly people on antipsychotic medications. They also 
indicated that the agranulocytosis caused by antipsychotic increases the risk of infection. 
Nevertheless those medications should not be regarded as potential risk of pneumonia because of 
the monitoring of the adverse effects such as swallowing problems, sedation may prevent the 
pneumonia. That is why clinicians must pay attention and carefully monitor the medications’ 
adverse effects. 
Schneeweiss, Setoguchi, Brookhart and Wang (2007:631) conducted a cohort study to explore 
risk of death associated with the antipsychotic medications in elderly people and found  that the 
risk of death was associated with both conventional (14.1%) and atypical (9.6%) antipsychotic 
medications. The cohort study by Setoguchi, Wang, Brookhart, Canning, Kaci and Schneeweiss 
(2008:1648) from 1996 to 2004 showed that with old antipsychotics the risk of death is highly 
associated with respiratory problems. However, the out hospital deaths are mainly due to 
cardiovascular diseases caused by old antipsychotics such as arrhythmia, cardiac arrest and 
sudden death.  The reviewed literature on risk of falls in the elderly people taking antipsychotic 
medication by Bulat, Castle, Rutledge and Quigley (2008:186) found  that the falls were 
associated with antipsychotic medication and the odds ratio from 49 reviewed  studies were 1.51 
for antipsychotic medication and the risk was greater if the patient was prescribed more than one 
medication. 
According to Atalay, Turhan and Aki (2007:833) the antipsychotic medications must be 
cautiously monitored after prescription, so that critical adverse effects are not unnoticed. Bulat et 
al. (2008:187) urged that to use antipsychotic medications with caution in elderly people because 
they may exacerbate the decreased gastrointestinal motility, urinary retention, prostate 
hypertrophy and visual problems by their anticholinergic adverse effects.  
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2.4.3 Antipsychotic medication in children 
 
The initiation of antipsychotic medications in children may consider that the children are more 
likely to develop the severe adverse effects. According to Fritz (2006:8) children may suffer 
from certain adverse effects (weight gain, diabetes) of antipsychotic medications for a long time 
even in adulthood. These endocrinal adverse effects may have mostly harmful effects as they 
increase the risk of morbidity and mortality in children (Rani et al., 2009:331). It is 
recommended to measure glucose and lipid levels three months after treatment initiation and 
every six months afterwards and health style changes as well as diet must be taught to family in 
order to manage metabolic effects (Correll et al., 2009:1772). 
The sedation is the most frequently observed adverse effect of antipsychotic medications.  
Chavez, Chavez-Brown, Sopko and Rey (2007:264) warned nurses to monitor and inform 
patients about the side effects because hyper-sedation leads to poor performance of school and 
impacts on other forms of therapy. The medication therapy in children require knowledge of 
most prescribed drugs, consideration of why they are prescribed and how it may improve child’s 
quality of life and for the family. The cautious use of antipsychotic medications, guarantee that 
the proper equilibrium between symptoms and adverse effects is preserved and the quality of life 
for child is improved (Self et al., 2010:373). 
2.4.4 Interactions 
 
The antipsychotic medications when administered with antihistamines, antidepressant and 
antiparkinsonian drugs may lead to anticholinergic effects and hypotension may be observed 
when associated with beta adrenergic blocking such as propranolol or metoprolol (Townsend, 
2003:304). The association of antipsychotic medications and immunologic drugs increase the 
severity of bone marrow suppression (Ford and Roach, 2009:449). The effectiveness of 
antipsychotics is decreased with antacids and barbiturates (Townsend, 2003:304). The depression 
of central nervous system may occur when antipsychotics are administered with antihistamines, 
antidepressants, sedatives hypnotics and anxiolytic and the alcohol (Townsend, 2003:305, 
Healey, 2009:24). Clozapine must not be associated with carbamazepine and phenytoin due to 
increased risk of agranulocytosis; never with lithium due to risk of seizures, confusion and 
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malignant syndrome (Ford and Roach, 2009:449, Sadock and Sadock, 2007:1096). The 
administration of antipsychotic medication with oral contraceptive can increase the risk of extra 
pyramidal adverse effects (Healey, 2009:24). Ford and Roach (2009:449) urged that nursing 
process must pay attention to drug interaction to prevent the side effects or/and ensure 
effectiveness of the medication. 
2.5 Nursing role in medication management 
 
It is highlighted in the literature that mental health nurses are the corner stone in the management 
of antipsychotic medication. This role requires them to view the effectiveness of the medication 
as the patient’s subjective satisfaction with treatment rather than the elimination of positive 
symptoms. The patient’ subjective satisfaction with different available medication must be a 
focus of medication planning and care framework. However, nurses must collaborate with 
patients and their care givers as they are in best position to describe the problem about 
medication, elaborate problem solving strategies and to elucidate the areas in which they would 
like to be helped (Clarke, 2008:435). 
2.5.1 Nursing assessment 
 
The poor physical health in people living with mental illnesses as a consequence to antipsychotic 
medication use has been highlighted in the literature (Clarke, 2008:435). As above mentioned, 
the antipsychotic medication may be harmful to physical health when they affect metabolic, 
neurologic and hormonal system. Diabetes mellitus, obesity, cardiac problems, amenorrhea are 
some examples of common physical problems. According to Gutierrez and Queener (2003:297), 
the assessment of present illness history, health history and physical examination must be done 
prior to initiation of treatment as well as considerations of life span and socio-cultural context.  
According to (Sadock and Sadock, 2007:227), a complete and sequential picture of the events 
principal to the present moment in the patient’s life are provided by the history of the present 
illness and the understanding of that history enables  clinicians to make a diagnosis. Gutierrez 
and Queener(2003:295)state that the first assessment is imperative as it determine the patient 
functioning and mental status and determine antipsychotic drug therapy. Initial assessment, 
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allows patients to talk freely as nurses identify the symptoms such as thoughts disturbances and 
strange behaviours. 
The physical examination allows the nurses to determine patients’ health parameters, to identify 
the underlying medical problems and to monitor the evolution of these illnesses as well as 
sensitivity of antipsychotic medication (Gutierez and Quenner, 2003:297). The physical 
examination is done to determine if a medical condition is not the cause of psychiatric disorder 
or if the medical condition is not a contraindication of antipsychotic drugs. It can be done also to 
assess the effect of mental disorders and medications on physical health (Sadock and Sadock, 
2007:249). 
Personal history helps to understand a patient’s past in relation to the present state in order to 
identify previous disorders. Thus nursing assessment aims to identify the predominant emotions 
associated with different stages of a patient’s development and give detailed information which 
is necessary for effective therapy (Gutierez and Quenner, 2003:297, Sadock and Sadock, 
2007:229). This assessment must take into consideration the individual lifespan such as 
pregnancy, adolescent which may be associated to stressors that lead to mental disorders. A 
patients’ beliefs have shown to be on the basis of mental problems and may play a role in the 
patient’s adherence to medication (Gutierez and Quenner, 2003:296). 
Schellack (2010:207) stated that medication management is one of the challenging task that 
nurses face daily. Medication management entails multiple activities including assessment and 
analysis of prescriptions, performance and management of prescribed treatment regimens, 
ordering storing and monitoring patients for wanted effects as well as adverse effects of the 
medications. 
2.5.2 Medication administration 
 
In many cases the prescription of medication is done by the doctors. Even though the 
prescription is done by the doctors, there is a shared responsibility with regard to medication 
administered to patient. However the administration of an incorrect dosage is the responsibility 
of the nurses even if the medication was incorrectly prescribed (Schellack, 2010:213). The 
management of medication requires nurses to be knowledgeable with good understanding of 
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medication prescribed to a patient in order to apply accurate evaluation and analysis of 
prescriptions. 
It is highlighted in the literature that medication must be accurately administered. Nurses 
reported that medication administration is stressful tasks in that sense it requires to be carefully 
administered in the midst of distractions and chaotic nature of a ward. The volume of work 
demand speed and that is directly conflicting with meticulous concentration and detail required 
to medication administration. Assessment of and correct identity of a patient as well as 
medication, patient’ condition and effects of medication at the same time sustain clear and 
correct records add to the pressure associated with this multifaceted procedure (Duxbury et al., 
2010:58). Schellack (2010:215) emphasized on the correct dosage and correct route of 
administration. A careful  count of tablets required, calculation of the volume is essential in 
medication administration as well as verification of patient’s capacity of swallowing of  oral 
route and ensure that correct diluents are used for injection. 
 The researchers stressed on the nurses’ need of documentation and up to date information in 
order to administer the medication is  needed and to monitor  patients (Usher et al., 2001:388, 
Baker et al., 2007:167). The authors recommend the availability and utilisation of 
documentation, a thorough nursing assessment prior and after medication administration as the 
medication administration is  one of the most autonomous nursing roles in inpatient settings 
(Usher et al., 2001:389) 
2.5.3 Treatment monitoring 
 
To detect the occurrence of adverse effect of medication, mental health nurses need to be 
knowledgeable about pharmacology and to understand the different predisposition to adverse 
effects that antipsychotics create. The information exchange with people using antipsychotic 
medication is source of empowerment for users to minimize the unpleasant effects associated 
with their medications (Clarke, 2008:346). 
Patient follow up must be scheduled and appointments for that process should include patients 
and their families. The medication monitoring process comprises of periodic assessment of 
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symptoms, adverse effects and patient satisfaction to determine the efficacy of antipsychotic 
medications.  
2.5.3.1 Clinical effectiveness monitoring 
 
The clinical effectiveness is demonstrated by the improvement of the symptoms and of global 
functioning. A mental health nurse plays a crucial role in assessing and reporting the observed 
improvement supported by both subjective and objective measures.  
The antipsychotic medications have shown effectiveness in calming agitated and excited patients 
and to alleviate social withdrawal thus improving communication. It is estimated in the literature, 
that one third of the patients demonstrate a brilliant symptom decrease and patients may not be 
re-hospitalized even when they stop medication and may return to normal life such as 
employment, and marriage (Meyer and Quenzer, 2005:450). Others may present important 
improvement of symptoms but could experience setbacks that necessitate hospitalization from 
period to period. Patient self-report, report of caregivers must be supported by clinical interviews 
and rating scales in order to obtain pertinent information to symptom shapes and functioning 
(Davies et al., 2010:100). 
2.5.3.2 Adverse effect monitoring 
 
It is urged that nurses must continuously stay observant in order to see and record the effects of 
medication therapy as the medication taken is associated with risk of serious problems such as 
malignant syndrome of neuroleptics (Valfre, 2009:75, Strauw et al., 2007:871, Neuhut et al., 
2009:415, Haddad and Dursun, 2008:20, Berman, 2011:43). However, it was found that 
medication monitoring may be hampered by nurses’ level of understanding and work conditions.  
It is reported that nurses were reluctant to ask the patient about medication when they were 
distributing medication in order to protect patient confidentiality (Duxbury et al., 2010:54).The 
nurses’ underestimation of problems associated with adverse effects will lead to aggravation of 
risks and therefore hamper patient ‘compliance. It is crucial to be knowledgeable about patient’ 
attitudes, feelings and beliefs about medication as that influence patient adherence. Lambert et al. 
(2005:17), Correll (2008:200) and Chen et al.(2009:21); underlined the need of  weight 
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monitoring with life style adjustment, blood glucose and  lipid level, blood pressure monitoring 
in order to detect early  medications’ adverse effects.  In order to manage the neurologic adverse 
effects, the literature highlighted the use of antichornergic drugs, stopping medication that cause 
the effect and choose another with low effects (Meyer and Quenzer, 2005:293, Haddad and 
Dursun, 2008:18). 
The malignant neuroleptic syndrome is managed by stopping all medications, rehydration, 
monitoring creatinine phosphate kinase level, administration of dopamine agonists such as 
bromocriptine and muscle relaxant such as dantrolen (Haddad and Dursun, 2008:20) monitoring 
of vital signs and electrocardiographic changes and administration of antipyretics (Gutierez and 
Quenner, 2003:293). Nursing assessment of therapeutic and non-therapeutic effect of medication 
is non-negotiable role and different tools are available to assist nurses in this process (Duxbury et 
al., 2010:59). 
2.5.4 Patient and Family Education 
 
Davies et al.(2010:106) urged that patient, family members and caregivers must be educated 
about pharmacological evidence and that will permit them to be aware of the dose modification, 
discontinuation, switching and combination of medication that may experience their relatives. 
The explanation to medication action and individual’s genetic constitution which may affect the 
response to medication must be in simple language that may be understood by non-medical 
people. A study by Lan, Shiau and Lin (2003:372) which evaluated knowledge, beliefs and 
attitude of Taiwanese patients revealed that patient knowledge of adverse effects was associated 
with negative attitudes to medication. They urged that careful attention must be paid by 
clinicians when they teach about adverse effects to patients as they may feel worried and be 
uncertain to take medication.  
It is challenging to mental health nurses to simplify the complexities of adverse effects 
particularly some troublesome effects such as weight gain and hormonal effects. Therefore they 
must inform patient and family members that antipsychotic medications are associated with 
unpleasant effect and that will help them to report and monitors those effects (Davies et al., 
2010:105). Hamann, Kruse, Schmitz, Kissling and Pajonk (2010:63) stressed that patients have 
the right to fully discuss medication management and not to be simply  informed. The fully 
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participation demands that a patient is informed about different treatment alternatives and then 
they are allowed to make choices according to their preferences. 
According to Lan, Shiau and Lin (2003:372), the mental health workers must assess a patient’s 
awareness and feelings about medication adverse effects and the team members must be 
consistent with information that is given to patients. The misinterpretation, uncertainties, 
confusion, level of knowledge and patient’s wishes, if assessed help to complete patients’ 
information and enforce patient education. The importance of medication must be underlined and 
clarified that the occurrence of adverse effects is not absolute. To that patient, family must be 
integrated into medication therapy and be responsible for reactions, adverse effects and 
observation. Patients must be taught to  manage their symptoms and adverse effects and that will 
help them to feel more responsible and decrease worries and anxiety (Lan et al., 2003:373). 
The discrepancy of opinions to the relative benefits of informing the patient about adverse effect 
is depicted in the literature. The enormous education support as an approach to enhance client 
knowledge and adherence is available. However, some health care workers argued that 
information to medication may increase anxiety and decrease adherence. 
In spite of the controversy, the key aspect in successful management of patient and their 
medication is empowering them. According to Uys and Middleton (2004:224) increased 
understanding of illness, treatment and the collaboration with health care providers allows 
patients and their families to have power over the illness as they gain self-confidence and release 
from  guilt and anxiety. Patients become more active participants in the management of their 
illnesses when they feel empowered and the motivation to adhere to medication increase. Psycho 
education and problem-solving strategies provided by mental health providers can contribute to 
the empowerment of patient and fostering a collaborative alliance that is the basis of quality care 
(Fernandez et al., 2006:76). 
2.5.5 Medication adherence 
 
The antipsychotics clinical efficacy is evident when a patient observes their prescribed 
medication. Mental health nurses have the responsibility to discuss with the patient with regard 
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to their attitudes toward medication, review and update medication plan in each session and to 
explain the patient’ responsibilities. 
The patient has a responsibility to take medication as prescribed, report adverse effects and to 
reveal the thoughts of non-compliance. However, that might not be possible in the absence of a 
trusted relationship and open communication and collaborative decision. Mental health nurses 
must be available and to listen to patients’ concerns about medication, discuss ideas about 
medication change or adjustment and to monitor adverse effects. This demands that mental 
health nurse should have knowledge about pharmacology and be skilled enough in therapeutic 
communication. 
The risk factors associated with non-adherence to antipsychotic medications using self-report 
scale was examined  by McCann, Boardman, Clark and Lu (2008:624) and awareness of illness, 
stigma related and importance of treatment was reported by over 80% of their respondents. 
However, it was not easy for those patients to adhere to treatment due to different factors 
described; 70% experienced unpleasant adverse events, and 10% abused the drugs. Rummel-
Kluge, Schuster, Peters and Kissling (2008:384) highlighted other contributing factors such as 
lack of understanding of need of prophylaxis, denial of illness and living conditions. 
Researchers have underlined the living conditions that predict the patient compliance such as 
accommodation (McCann et al., 2009:540) access to care (McCann et al., 2008:625) and 
supportive environment (Janssen et al., 2006:234). The factors that predict the non-compliance 
such as adverse effects, age, inaccessibility of care, alcohol abuse (McCann et al., 2008:625), 
patient state, negative judgement from clinicians (Janssen et al., 2006:234) have been revealed. 
 It is advised to include a supportive person in the medication planning if needed to improve 
patient compliance (Davies et al., 2010:103). A study by Rummel-Kluge, Schuster, Peters and 
Kissling(2008:384) revealed the need of patients to be reminded by others to take their 
medications. Wilk, West, Marcus, Countis, Regier and Olfoson (2008:379) evaluated the role of 
family in patient adherence to medication and urged that  mental health workers multifaceted 
interventions must intensity family contact. The low level of family contact was associated with 
low medication monitoring, low patient involvement and thus low adherence. 
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McCann, Clark & Lu (2009:537) explored the role of significant others in medication adherence 
and found out that that they intervene in supervising medication taking, encouraging patients to 
respect appointment and providing accommodation, maintaining trusting and supportive 
relationship.  The role of mental health nurses and others clinicians in promotion of patient 
adherence to medication is indisputable. According to Drymalskin and Campbell (2009:12) the 
motivational interviews are essential instruments for nurses to help patients to be compliant with 
medication. Patel, Ni, Clarton, Lam and Park (2010:273) emphasized on cognitive-behavioural 
therapy associated with psychosocial interventions. Janssen et al. (2006:234) urged that nurses 
must adjust their treatment model to individual patients, prevent and monitor adverse effects, 
establish good relationships with patients, to promote therapeutic alliance. According to 
Rummel-Kluge et al., (2008:386), to gain patient’ adherence, nurses must rationalise the 
antipsychotic medication regimens, provide telephone a support, apply psychosocial 
interventions and promote supportive environment. 
2.6 Conclusion 
 
This section highlighted the literature on antipsychotic medications’ action, effectiveness, 
adverse effects and the management related issues. It was noted that the antipsychotic 
medications are crucial in the management of psychosis and other mental disorders. However, 
their actions in the brain produce both positive and a number of unwanted adverse effects. These 
unwanted effects may be life threatening or alter a patient’s physical health (McCreary and 
Jones, 2010:516). The common adverse effects were extra pyramidal adverse effects, 
cardiovascular adverse effects, weight gain and anticholinergic adverse effects. The 
antipsychotic medications had also many interactions with other drugs and may be administered 
with caution to some groups such as pregnant women, elderly people and children. Finally, the 
effectiveness and adverse effects of monitoring have been found to be crucial in the management 
of mental disorders and promotion of a patient’s quality of life. It was highlighted that nurses are 
at the centre of medication management through  patient assessment (Gutierrez and Queener, 
2003:297), monitoring of administered treatment, patient education and promotion of adherence 
strategies (Meyer and Quenzer, 2005:453, Rummel-Kluge et al., 2008:386, Lan et al., 
2003:372).The following section describes the methodology that was used for this study. 
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 Corbin and Strauss (2008:1) define research methodology as “A way of thinking about and 
studying social phenomena”. In this process, there is use of different techniques and procedures 
to gather and analyse the data.  
This section describes the research approach, setting and design. The sampling procedure, tools 
used to collect data, how data was managed and analysed, ethical issues that arose during the 
course of study and precautions that were taken to manage these.  
3.2 Research paradigm and approach 
 
A positivist understanding of how the social and physical world can be known and studied  
shapes and  influences a research study (Polit and Beck, 2008:15). The positivism paradigm 
argues that there is a possibility to understand and describe the reality of specific phenomena 
through direct observation and measurement of its discrete aspects (O’Leary, 2004:5). A 
positivism paradigm refers to the traditional paradigm underling the scientific approach, which 
assumes that there is a fixed, orderly reality that can be objectively studied; often associated with 
quantitative research (Polit and Beck, 2008:15). Burns and Grove (2005:22) stressed that the data 
resulting from the observation and measurement is therefore numerical represented, is shown to 
be true beyond doubt and has applicability beyond the sample of  a wider population.  
3.3 Research design 
 
 A non-experimental exploratory quantitative cross sectional survey design that is descriptive in 
nature informed this study. The importance of a health condition or a phenomenon is usually 
measured in terms of the extent to which that phenomenon is present in a population at risk/or 
the incidence of new case at single point in time (Polit and Beck, 2008:20). Thus, the objectives 
of a descriptive design are  observation, description and documentation of a situation as it 
naturally happens (Polit and Beck, 2008:274). For this study the descriptive design was chosen to 
enable the researcher to identify the knowledge gaps, justify and making judgement on 
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medication management. Therefore, in this study the nurse’s knowledge on antipsychotic 
medications was explored, described and categorised in order to give the frequency distribution 
and mean score. 
3.4 Research setting 
 
This study was conducted at Ndera Neuro-Psychiatric hospital, in Rwanda. Rwanda is a low 
income country situated in East Central Africa with an area of 26,336 square kilometres; its 
population is estimated to be 10, 412,826 within four provinces and Kigali city (National 
Institute of Statistics of Rwanda, 2011:2). The official languages are Kinyarwanda, French and 
English. This study was conducted at Ndera Neuro-Psychiatric hospital the only one psychiatric 
hospital in the country. 
Ndera Neuro-Psychiatric Hospital is located in Gasabo district in Kigali city, and is a 
government assisted facility headed by the Brothers of Charity and is one of four referral 
hospitals in the country and with two branches: Icyizere Psychotherapeutic located in Kicukiro 
district in Kigali city and CARAES Butare situated in Southern Province, Huye district. 
Ndera Neuro-Psychiatric hospital activities include preventive, promotive, curative and 
rehabilitative specialised mental health and neurological care and as referral hospital in mental 
health, Ndera Neuro-Psychiatric hospital provides training and support to district hospitals. Its 
human resources (2010) is composed of 82 nurses (1 registered nurse with honours degree in 
mental health, 55 registered nurses in mental health  and 4 registered  general nurses, 20 enrolled 
nurses, 2 nurse auxiliary ), 2 neurologists, 1 psychiatrist, 6 medical doctors, 11 social workers, 4 
psychologists and 2 public health officers and 1 pharmacist. 
The hospital has 321 beds for all branches, including 250 beds in the main hospital, 63 beds at 
CARAES Butare centre and 8 beds at Icyizere psychotherapeutic centre. The main hospital is 
divided into 6 wards including male and female acute, male and female rehabilitation, the 
children and adolescent ward and the home care ward. The hospital also has an outpatient 
department which provides services on trauma counselling and psychotherapy, consultation 
rooms, occupational therapy service, neurology unit and social work service. It has neurology 
laboratory, general laboratory and the pharmacy. CARAES Butare centre has 2 wards, one for 
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women and one for men, consultation rooms and pharmacy and Icyizere psychotherapeutic 














Figure 3.1: Rwanda map 
http://www.guideforafrica.com/rwanda/rwanda-map.html 
At Ndera hospital psychiatric nurses are allowed to prescribe medication in outpatient service for 
the main hospital and for in and out patient for Icyizere psychotherapeutic centre and CARAES 















Burns and Grove (2005:344) defined study population as the entire set of individuals or elements 
that meet the researcher’s set criteria of selection. For this study the target population is 
composed of all nurses (N=82) working at Ndera Neuro-Psychiatric hospital, the main hospital 
and its branches. 
3.6 Sample and sampling 
 
The individuals who accurately reflect the population studied in relation to variables under 
investigation and consideration of others variables that may impact on the study was assessed 
(Polit and Beck, 2008:291). For this study the researcher adopted a non-probability sampling 
technique using a convenient and purposive approach. The study aimed to implement a census 
and thus all nurses, who were working at Ndera Neuro-Psychiatric hospital during data collection 
period who met the inclusion criteria, are subjects of this study. All nurses (nurse auxiliary, 
enrolled nurses, registered nurses) working at Ndera Neuropsychiatric hospital who were 
involved in any or all aspects of medication management (prescription, ordering, transcribing, 
storage, administration and monitoring) at work during the data collection period. Two nurses 
who were involved only in administrative duties were excluded from this study as they were only 
involved in billing and filing. 
3.7 Data collection instrument 
 
A self-report questionnaire was used in this study consisting of three sections. Section A was for 
demographic data that is sex, age, experience, qualification of participant and training in 
pharmacology. Section B had data pertaining to nurses’ knowledge of antipsychotic medication 
and Section C focused on nurses’ practice by collecting data related to nursing management of 
antipsychotic medication (Appendix 1, 2). The researcher modified two instruments which were 
initially developed by Byrne et al. (2005:520) and Amstrong-Esther et al. (2008). The instrument 
by Byrne et al. (2005:520) was developed to explore nurses’ knowledge, beliefs and difficulties 
in implementing the adherence strategies, based on medication used in their context and the 
adherence strategies interventions. For this study, beliefs items were not used as the study only 
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explored nurses’ knowledge of antipsychotic medication. Amstrong-Esther et al. 
(2008)developed their instrument to demonstrate nurses’ knowledge of antipsychotic and their 
use in older persons based on voluntary guidelines for drugs and dementia (Levenson, 1998). 
Some statements were modified to suit this study and the Likert Scale (strongly agree, agree, 
neutral, disagree, strongly disagree) was used to rate the nurses’ knowledge.  
3.8 Validity and reliability 
 
Validity is defined by Burns and Grove (2009:380) as a determination of the extent to which the 
tool reflects the abstract constructs being examined. The content validity is ensured by checking 
items in data collection tool against the study objectives and concepts in conceptual framework 
and the extent to which these items are reflective of current research results. The data collection 
tool is adopted from the previous researcher, so it was reviewed by a panel of experts in research 
and mental health nursing and management (mental health officer in Ministry of health with 
PHD in mental health nursing, Three academicians (two with masters in mental health nursing 
and one with masters in nursing management). The panel members made an individual 
judgement and rating on each item and then compared their rating score for each item so that the 
items which were rated as inappropriate were removed. The table below shows the content 












Table 3.1: Content validity 
 
Reliability means the degree of consistency with which an instrument measures the attribute it is 
designed to measure (Polit and Beck, 2008). The questionnaires used previously by Byrne et al. 
(2005) and Amstrong-Esther et al. (2008) have proven valid and reliable (Cronbachs alpha 0.60). 
However, the instruments have never been used in Rwanda and others questions has been added. 
The test reliability was therefore done according to  section B7 measuring understanding (27 
items) was reliable (Cronbach’s alpha 0.77), Section B8 (10 items) measuring knowledge of 
antipsychotic medication’ names (Cronbachs alpha 0.67), Section C10 (14 items) measuring 
Objectives Conceptual 
framework 
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knowledge about medication compliance (Cronbach’s alpha 0.92)and  section C11 (12items) 
measuring knowledge on medication education was reliable at (Cronbach’salpha 0.89).The 
instrument was translated from French to produce terms equivalent to an English version and 
facilitate French speaker nurses to complete it. The translated version was reviewed by mental 
health experts from Kigali health Institute to ensure that the translated instrument had 
appropriate meaning. 
3.8 Pilot study 
Pilot testing is an important element of study design and may be used for different reasons. In 
this study it was used to assess whether the research instrument is realistic and practical. It was 
used to examine whether there are any ambiguous questions, misspelt words or whether the 
vocabulary was clear and appropriate for the respondents. Five nurses were asked to participate 
in the pilot study to evaluate the instruments in terms of comprehensiveness, user friendliness as 
well as time taken to complete in order to predict the problems a researcher may encounter 
during the study. Based on results of the pilot study, some changes were considered to increase 
the practicality and clarity of instruments. 
3.9 Data collection procedure 
 
The research proposal was submitted to the University of Kwa-Zulu Natal authorities for review 
and ethical approval and permission to conduct the research was sought from Ndera Neuro-
Psychiatric authorities. 
Before commencing data collection, an introductory and informative session was held with the 
nurses and nurse managers of Ndera Neuro-Psychiatric hospital to explain the purpose of the 
investigation, to request them to participate in the study and negotiate the convenient time to 
collect data and the written information document was furnished to them. 
Appointments were made with the nurses when they were available. The researcher informed 
participants of their rights and explained issues of anonymity and confidentiality in relation to 
the study. The participants were requested to sign an informed consent once they agreed to 
participate in the study. 
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The participant was seen individually and the questionnaire was delivered by hand to each 
participant by the researcher who self assisted them and returned to the researcher by placing 
them in a box which was located in the unit manager’s office. A covering letter, detailing the 
information about the study and the consent was included as well as clear and concise 
instructions for completing questionnaire (Appendix 3, 4). To maximize the number of 
participants and to include all categories of nurses, as with the hospital planning all nurses had to 
be available within 5 working days, the researcher spent a week collecting data and during the 
night shift to see the nurses who were not available within five days. 
3.10 Data analysis 
 
Data was entered into the Statistical Package for Social Sciences (SPSS), version 19.Descriptive 
statistics was used to describe and synthesize data. Categorical variables were summarized using 
frequency distribution and presented in tables, bar and pie charts. The numerical variables 
(knowledge scores) was summarized by the measures of central tendency (mean, minimum and 
maximum) and measures of variability (standard deviation). Non parametric tests (Mann-
Whitney U test was used to test difference between sex across the score, Kruskal-Wallis test to 
test difference in more than two groups); Chi- Square test was used to test groups’ differences 
with regard to the level of knowledge. 
3.11 Ethical considerations 
 
Ethical considerations are vital to any study because of the influence the researcher has to 
acquire and retain respondents (Polit and Hungler, 1999:132).  
The research proposal was presented to the School of Nursing and then submitted to the Ethics 
Committees at the University of Kwa-Zulu Natal and Kigali Health Institute for approval. The 
approvals and ethical clearance number are provided in Appendix (10, 11) and the permission to 
conduct the research has been obtained from Ndera Neuro-Psychiatric hospital (See Appendix 9) 
The rights of participants were respected. Those rights were underlined by Burns and Groves 
(2009:611) and include right to self-determination, right to privacy, right to anonymity and 
confidentiality, right to fair treatment and right to protection from harm or discomfort.  
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Informed consent was obtained from the participants after explaining the purpose of the study 
(See Appendix 5, 6). The researcher provided information on a sheet as well as verbally to the 
participants in order to ensure their right to additional information about the study. The 
participants voluntarily participated in the study and had the right to withdraw from the study 
without any prejudice; all information will remain confidential and will be kept by the 
researcher, in a locked cupboard and then destroyed after five years of analysis and report the 
findings.  
To ensure scientific honesty, the researcher acknowledged the ideas or Works from others that 
were used in this study. 
3.12 Dissemination of the findings 
 
The findings of this study will be presented to the University of KwaZulu-Natal in hard copies 
and soft copy. A hard copy of the study will be made available to the Kigali Health Institute 
library and to Ndera Neuro-Psychiatric hospital. The findings will also be presented to the 
Taskforce of pharmacy in the Ministry of health. The researcher and supervisor will publish the 
findings in an accredited scientific Nursing Journal. 
3.13 Conclusion 
 
This section outlined the research methodology which was followed in this study. It also 
highlighted the procedure that was used to collect the data as well as the measures  takento 












This chapter presents the finding of this study. The main aim was to explore nurses’ knowledge 
of antipsychotic medication, its management and factors associated with their knowledge. Data 
collection was done using a self-administered questionnaire with was composed by three 
sections: section one focused on participant demographic data, section two  evaluated knowledge 
on antipsychotic (therapeutic effects, antipsychotic name and its adverse effects) and section 
three evaluated nurses’ knowledge on monitoring practices of a patients under antipsychotic 
medication.  
Analysis was done using the Statistical Package for the Social Sciences (SPSS) for Windows, 
version 19. For the analysis of the study, negative responses “strongly disagree, disagree and 
neutral” was grouped together and rated as “0” and the positive responses “agree and strongly 
agree” were grouped together and rated as one. The mean score of each section was calculated as 
well as the total score knowledge and the participants were categorized according their level of 
knowledge (low, medium and high). The level of knowledge was determined by a team of 
experts in mental health after examining the questionnaires items. Respondents with score < 50% 
were considered as having low knowledge, score from 50% to < 75% was considered as having 
medium knowledge while those with score ≥ 75% were considered as having high knowledge. 
The non-parametric tests were used for analysis of associations as the data were skewed. 
According to Polit and Beck (2009:591), the non-parametric tests are mainly practical when data 
is not normally distributed. Therefore Mann-Whitney U test was used to test difference between 
sex across the score, Kruskal-Wallis test to test difference in more than two groups and Chi- 
Square test was used to test groups differences in regard to the level of knowledge. Data are 
presented with the aid of frequency tables, bar graphs, percentage and scores as deemed 
appropriate. 
The presentation of the results is in accordance with the objectives of the study. The 
demographic characteristics of respondents were described followed by presentation of score and 
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level of knowledge of therapeutics effects, identification and adverse effects of antipsychotic 
medication; knowledge and level of antipsychotic medication management, and the association 
between demographic characteristics of respondents and their knowledge scores. 
4.2 Demographic characteristics of the sample 
 
The demographic variables for this study include gender, age, and years of experience as a nurse, 
experience at Ndera Neuro-Psychiatric hospital, qualification and training in 
psychopharmacology. These variables were selected on the basis of previous studies which were 
found to play a role in gaining knowledge on medication management (Simonsen et al 2011:11, 
Dilles et al, 2010). 
4.2.1 Gender and age 
 
The findings of this study show that over one half (n= 40 of 73 or 54.8%) of the sample were 
female and (n=33, 45.2%) were male. The largest portion of participants (n=45; 61.6%) were 
found in the 26-35 age group. The second largest portion of participants (n=20; 27.4%) were 
found in the 36-45 age group. The early (25 years and fewer) and the later age group (46 years 
and more) were found at equal percentage (n=4, 5.5%). These findings are summarized in table 
4.1 
Table 4.1 Gender and age 






Male 33 (45.2%) 
 
25 years and lesser 
 















4.2.2 Respondents nursing experience and experience in psychiatric setting 
 
For the purpose of this study, respondents were asked to state their experience in category of 
years and most participants are young in nursing profession (n=34; 46.6%) having not had more 
than 5 years of experience. This was followed by participants (n=20; 27.4%) with 6-10 years of 
experience. The majority (n=46; 63%) have worked at HPN-Ndera hospital for 0- 5 years, 
pursued by participants (n=20; 27.4%) who have had 6-10 years of experience at the same 
hospital. There is one (1.4 %) respondent who has more than 20 years as a nurse and has worked 
at Ndera hospital for more than 20 years.  
Table 4.2 Nursing experience and experience in psychiatric setting 
 













Experience as a nurse 











  6 (8.2%) 
 
Experience at Ndera hospital 










4.2.3 Qualification of respondents 
 
The majority of nurses in the sample (n=45; 61.6%) have an advanced diploma in mental health 
nursing equivalent to three years of education in higher learning institution in Rwanda. The 
predominance of advanced mental health nurses may be explained by the fact that the HNP-
Ndera hospital is a potential recruiter as it is the only psychiatric hospital in the country. The 
advanced diploma is referred to A1 level in French system. Enrolled nurses (A2), occupy second 
place with (23.3%, n= 17). Only 3 nurses (4.1%) had a postgraduate level, respectively (n=2; 
2.7%) with honours -degree and (n=1; 1.4%) with a master’s degree. George, 
Henneman&Tasota(2010:s142) stressed that  high levels of education is  crucial in gaining 
understanding of high risk medication management. 
 
 











4.2.4 Training in psychopharmacology  
 
The highest portion of participant (n=59, 80.8%) had an academic training in 
psychopharmacology. This may be explained by the fact that the majority of participants had 
undergone study at higher learning institutions. In service training is the second method of 
training (n=8; 11%). Workshops (n=3; 4.1%) as well as peer education (n=3; 4.1%) were also 
used to train the participants in this study. 
 















In service training 
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4.3 Participants’ knowledge on antipsychotic medication 
 
To explore knowledge of participants 53 items questionnaires were asked ( 27 items regarding 
therapeutic effects, 10 items regarding knowledge on medications names and 16 items related to 
adverse effects) which  give a score of 53 (100%). The mean score was 64.22% with a standard 
deviation 9.83%. The lowest score was 41.51% and the highest score was 86.79%. The majority 
of respondents had medium knowledge (n=55, 75.3%) and n=9 (12.3%) with  low knowlegde 
and only n=9(12.3%) had a high knowledge. 
 

















Low Medium High 
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4.3.1. Participants’ knowledge on therapeutic effects of antipsychotic medication 
 
In order to establish the level of knowledge regarding the therapeutic effects of antipsychotic 
medication 27 questions were asked. The summed correct responses to these questions could 
give a possible score of 27 (100%). The mean score was 72.85%with 14.99%as standard 
deviation from the mean. The lowest score was 18.52% and the highest was 100%. The level of 
knowledge on different therapeutic effects of antipsychotic medication was slightly different 
between highly knowledgeable (n=33, 45.2%) and medium knowledgeable (n=32, 43.8%); (n=8, 
11%) of respondents with low levels of knowledge. 
 
Figure 4.4 Level of knowledge on antipsychotic medication therapeutic effects 
 
4.3.2 Knowledge of antipsychotic medication name 
 
The respondents were asked to identify if the actual medication is antipsychotic medication. The 
score were calculated based on the respondents’ responses ‘no’ and ‘don’t know’ were 
considered as ‘negative’ while ‘yes was ‘positive’. The total score for correct responses was 10 











Low Medium High 
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was 30% and the highest was 100%. The respondents showed high knowledge levels as 
evidenced by (n=50, 68.5%) who are very knowledgeable and (n=21, 28.8%) of participants who 
are knowledgeable. A small number has shown to be not knowledgeable (n=2, 2.7%). 
 





















Low Medium High 
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4.3.3 Knowledge on adverse effects of antipsychotic medications 
 
In this section, the participants were asked to identify which adverse effect of antipsychotic 
medication is caused by the old or new generation antipsychotic or if it was caused by both. The 
number of items was 16 and correct responses were 16(100%). The mean score was 38.61% with 
12.38% deviation from the mean. The highest score were 62.50% and the lowest score were 
6.25%. The participants were categorized according their score and predefined criteria. Low 
levels of knowledge were found among the  participants with regards to differentiating the 
adverse effects in regard to underlying antipsychotic class as evidenced by n=49(67.1%) and 
only 24 (32.9%) who had medium knowledge and no one was very knowledgeable. 
 












Low Medium High 
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4.4 Knowledge on the benchmarked monitoring practice of patient taking 
antipsychotic medication 
 
To establish participants’ knowledge on monitoring practice of patient taking antipsychotic 
medication, the score of two questions in the questionnaire were summed as sub score of total 
knowledge ( 14 items on monitoring patients ‘compliance to antipsychotic medications and 12 
items on patient and family education about antipsychotic medication). The total score was 26 
(100%). The mean score was 79.50% with a standard deviation of 20.20%. The minimum score 
was 0% and the maximum was 100%. The majority of participants were very knowledgeable 
(n=48, 65.8%), n=20 (27.4%) scored knowledgeable and n=5(6.8%) scored not knowledgeable. 
The results showed a big difference between participants as the score ranged from 0 to 100%. 
 
 













Low Medium High 
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4.4.1 Knowledge of monitoring of patient compliance to antipsychotic medication 
 
The question that addressed monitoring of patient compliance to antipsychotic medication was 
composed of 14 items considered as important nursing practice to promote compliance. Each 
correct question was rated as “1” and the total score were 14(100%). The mean score was 
83.75% and deviation from the mean was 22.75%). The highest score was 100% and the lowest 
was 0%. The participants showed a high level of knowledge as evidenced by (n=55, 75.3%) of 
those who were very knowledgeable (n=13, 17.8%) of those who had medium knowledge and 
only (n=5, 6.8 %) who had low levels of knowledge. 
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4.4.2. Knowledge of patient and family education practices 
 
In order to determine participants’ knowledge on patient and family education 12 item questions 
were asked. The possible score was 12 (100%) was summed up by positive responses. The mean 
score was 74.54% with a deviation from the mean of 23.54%. The highest score was 100% and 
the lowest was 0%. The majority of participant were very knowledgeable (n=45, 61.6%) 
followed by knowledgeable participants (n=19, 26%) and 9 (12.3%) participants with low 
knowledge levels. 
 





















Low Medium High 
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4.5. The overall score knowledge on antipsychotic medication 
 
In order to determine the total score knowledge on antipsychotic medication all items in 
questionnaire were considered. The summed score for all correct responses was 79 (100%). The 
mean score for the total knowledge was 68.04%, with a deviation from the mean of 11.53%. The 
highest score was 90% and the lowest was 29%. The overall picture of participants’ knowledge 
of antipsychotic is medium as shown by 65.8% (n=48) who are knowledgeable, 24.7% (n=18) 
who were very knowledgeable and 9.6 (n=7) who were not knowledgeable. 
 















Low Medium High 
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4.6 Association between nurses’ demographic variables, their score and level 
of knowledge 
 
The knowledge of antipsychotic management was divided into 5 scoring categories: knowledge 
of therapeutic effects, identification of medication name, identification of adverse effects, 
knowledge of compliance promotion practice and knowledge of patient and family education 
practice. The two subcategories which were made included knowledge of antipsychotic 
medication (therapeutic effects, name and adverse effects) and knowledge of antipsychotic 
management (promotion of compliance, patient and family education). All five categories were 
added up to make an overall knowledge score.  The mean score of each category was found as 
illustrated in table 4.3 
Table 4.3 Mean score knowledge according category 
Category Mean score SD 
Knowledge score on therapeutic effects 72.85% 14.99% 
Knowledge score on antipsychotic medication name 81.91% 16.88% 
Knowledge score on adverse effects 38.61% 12.38% 
Sub-score knowledge on medication 64.22% 9.83% 
Knowledge score on patient’ compliance promotion practices 83.75% 22.75% 
Knowledge score on patient and family education 74.54% 23.52% 
Sub-score knowledge on medication management 79.50% 20.20% 
Overall knowledge score 68.04% 11.53% 
 
The mean scores suggest that respondents are more knowledgeable in some aspects of 
antipsychotic medication and less knowledgeable in others therefore affecting their overall 
knowledge. To establish the factors contributing to nurses’ knowledge about antipsychotic 
medication a decision was taken to explore how the demographic variables  may influence the 





4.6.1 Association of respondents’ gender and their overall score knowledge on 
antipsychotic medication 
 
In this study, there was no statistically significant difference (p-value of 0.885) in knowledge 
between males and female as evidenced by Mann-Whitney U test which revealed that knowledge 
level of antipsychotic medication for males (Md=69.62, n=33) and females (Md=69.62, n=40), U 
test value =647, z=-.144. Furthermore, the difference was explored between the categories of 
knowledge and the results yielded no statistical difference as illustrated in table 4.4 
Table 4.4 Association of gender and level of knowledge 
Level of knowledge P-value Gender 
Low Medium High Total 
Female 4 (10%) 26 (65%) 10 (25%) 40(100%) 




4.6.2 Association of age of respondents and their score knowledge on antipsychotic 
medication 
 
There was no difference in the median between the group aged of 25 years and fewer and the 
group aged between 26-35 years (Md=70.89). However, there was a difference in other groups, 
those aged between 36-45 years (Md=68.35) and the group aged 46 years and more (Md=65.13). 
Even though there is slight diminution of the mean with old age, there was no statistical 
significant response observed (X2=4.320, df=3, p=0.229). The chi-square test for independence 
also revealed  no significance between level of knowledge (low, medium and high) and age 
groups for the respondents (p=.792). 
4.6.3 Association of years of experience as a nurse and participants score knowledge 
 
The participants who have 6-10  years of experience scored high median (70.89), followed by the 
participants who have more than 20 years of experiences and  participants who have experience 
of 0-5years (69.62), median of  for the participants who have 11-20 years of experience as a 
nurse scored the lowest median (63.29). These differences among experience age groups yielded 
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no statistical significance as evidenced by a p-value of 0.382, x2= 3.063 with the degree of 
freedom of 3. The study further explored the differences according the level as illustrated in 
figure 4.5 
Table 4.5: Association of participants’ gender and their level of knowledge 
 
 
The group with 6-10 years of experience in the nursing profession had the highest percentage 
(76%) of knowledgeable with regards to antipsychotic medication. The group with experience of 
0 to 5 years of experience had the high number of very knowledgeable compared to other groups 












                   Level of knowledge  Experience 
as a nurse Low Medium High Percentage 
P-
value 
0-5 years 4 (11.8%) 20 (58.8%) 10 (29.4%) 34 (100%) 
6-10 years 1 (4%) 19 (76%) 5 (20%) 25 (100%) 
11-20 years 2 (15.4%) 8 (61.5%) 3 (23.1%) 13 (100%) 
More than 20 
years 





4.6.3.4 Association of years of experience at the actual hospital and their score knowledge 
 
A Kruskall-Wallis test revealed no statistical significant difference (p=0.653) in knowledge level 
across four groups (goup1, n=46: 0-5 years; group2, n=20: 6-10 years, group3: n=6: 11-20 years 
and group 4, n=1: more than 20 years). Group 4 scored highest median (Md=78.48) followed by 
group2 with (Md=70.25), group1 (Md=69.62) and the participants with medium experience 
(group3) scored the lowest median (Md=68.35). 
Table 4.6 Association of years of experience at the actual hospital and level of knowledge 
                   Level of knowledge  Experience at Ndera 
hospital Low Medium High Percentage 
P-value 
0-5 years 5 (10.9%) 29 (63%) 12 (26.1%) 46 (100%) 
6-10 years 2 (10%) 15 (75%) 3(15%) 20 (100%) 
11-20 years 0 4 (66.7%) 3 (33.3%) 6 (100%) 




4.6.4.5 Association of participants ‘qualification and their score knowledge 
 
A statistical significant difference (p=0.010) was found in knowledge on antipsychotic 
medication across six different groups qualification (group1, n=2: Nurse auxiliary, group2, n=17: 
enrolled nurses, group3, n=45: advanced diploma in mental health, group4, n=6: advanced 
diploma in general nursing, group5, n=2: bachelor in nursing and group5, n=1: masters). The 
group with a bachelor’s degree 
In nursing scored high median (Md=73.42) followed by the group with advanced diploma in 
mental health (Md=72.15). It was not expected that nurse auxiliaries would score a high 
(Md=70.89) than the other remaining groups (advanced diploma in general nursing: Md=69.62; 
enrolled nurses: Md=65.82) and masters with the lowest score (Md=29.11%). The statistical test 
(Chi-square) was performed to determine the relationship between their level of knowledge and 




Table 4.7 Association of participants ‘qualification and their level knowledge 
                   Level of knowledge  Qualification 
Low  Medium High Percentage 
P-value 
Nurse auxiliary  1 (50%) 1(50%)  2(100%) 
Enrolled nurse 4(23.5%) 12 (70.6%) 1(5.9%) 17(100%) 
Advanced  
Diploma in mental health 
2(4.4%) 29(64.4%) 14(31.1%) 45(100%) 
Advanced Diploma in 
general nursing 
 5 (83.3%) 1(16.7%) 6(100%) 
Bachellor in nursing  1(50%) 1(50%) 2(100%) 




As illustrated in the table above, the majority (three groups) of the participants were 
knowledgeable. It was not expected for a participant with a master’s degree to be not 
knowledgeable with regards to antipsychotic medication. 
 
4.6.5.5 Association of participants training and their score of knowledge 
 
A Kruskall-Wallis test revealed no statistical significant difference (p=0.308) in knowledge 
across the four groups (group 1, n=59: training in academia, group 2, n=3: workshop training, 
group 3, n= peer education training and group 4, n=8, in service training). The participants 
trained in academia had the highest score (Md=70.89), followed by the participants who were 
trained in workshops (Md=69.62), participants trained through in service training (Md=66.46) 
and participants trained by peers scored (Md=64.56). The chi-square test was performed to 
determine relationship between nurses level of knowledge and educational training and no 






In this chapter, data was presented from the main findings of the study. Overall findings showed 
that nurses working at Ndera Neuro-Psychiatric hospital had medium knowledge on 
antipsychotic medications. The study shows  that nurses with high levels knowledge on some 
aspects of medication (medication name, monitoring patients’ compliance) but average 
(therapeutic effects, family and patient education) and poor knowledge (adverse effects) for 
others. These findings are somehow contradictory as the knowledge on adverse effects is crucial 
in other aspects of medication such as patient and family education and monitoring of patients’ 
compliance to medication. Nursing role in antipsychotic management necessitates in-depth 
knowledge than that observed through this study’s findings. Therefore, this is an indication that 
nurses need further training especially pragmatic psychopharmacology in order to help them to 
better fulfil their role. 











Chapter five: Discussion of the finding 
5.1 Introduction 
 
This chapter concludes the study with a discussion on the results presented in chapter four, 
recommendations as well as the study’s limitations.  
For this study positivism, exploratory and non-experimental design was used to achieve the 
purpose of the research. The objective of this study was to assess nurses’ levels of knowledge on 
antipsychotic medication; determine nurses knowledge on health education as well as 
characteristics associated to their knowledge. 
5.2 Demographic Information 
 
In this study there were 40 (54.8%) female and 33 (45.2%) males bringing the total number of 73 
participants. This is consistent with country profile were 66% of nurses are female (African 
Health Workforce Observatory, 2009:26) The high number of females may be explained by the 
fact that nursing has been dominated by females as highlighted in other studies (Pudney and 
Shiels, 2000). The modern nursing profession is associated with feminization (Evans, 2004:325) 
as nursing education has failed to provide an environment that is conducive to attract men in the 
profession (O’Lynn and 2004:230) In the study by Pudney and Shield (2000:368), 90% of 
qualified nurse were female contrary to this study where the number of  males is quiet high 
(45.2%). These results are consistent with the results of the study conducted in Australia by 
Gough and Happel (2009:3160) who found that mental health nursing has a high number of 
males than other nursing specialities. 
The findings of this study reveal that the majority of nurses (61.5%) were young (aged between 
26-36 years). These findings are quite similar to the national profile as evidenced in the study by 
Africa health workforce observatory (2009:30) where the majority of the nursing workforce 
ranges between 31-40 years old. However those results are different from those of the United 
Kingdom where nursing profession is challenged by the retirement of an ageing nursing 
workforce (Bennett and Maben, 2007:62). Most of the nurses (46.6%) have an experience of 0-5 
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years in the profession, followed by those who have 6-10 years of experience. The results also 
show that the majority (63%) have few years of experience (0-5 years) at Ndera Neuro-
Psychiatric hospital. This may be explained by the fact the country has a young population, one 
third of the Rwandan population is aged between (15-34 years) and that most of the workforce 
was killed and others exiled during the genocide against Tutsi in 1994 (Schaal and Elbert, 
2006:100). 
In this study, the number of nurses with advanced diploma in mental health nursing (61.1%) was 
higher than others qualifications. This is not surprising as Ndera Neuro-Psychiatric hospital is a 
unique psychiatric hospital in the country employing most of the mental health specialists. It is 
promising to find a small number of enrolled nurses (23.3%) and it shows that nurses are 
upgrading their studies at high levels (high school and universities). According to Roxburgh, 
Tayror and Murebwayire (2009:350), the enrolled nurse training programmes were phased out in 
order to train nurses at advanced level. The number of nurses with a postgraduate degree is still 
low as  training at that level has only been  recently initiated at Kigali Health Institute and the 
few post graduate nurses have been trained abroad, particularly in South Africa (Ministry of 
health, 2007:20). 
5.2 Nurses knowledge on antipsychotic medication 
 
The results of this study showed that more nurses were knowledgeable on antipsychotic 
medication. This was considered as average because the participants could achieve the score of 
80% if they agreed with all statements. Based on the nature of questions and the fact that the 
nurses manipulate daily antipsychotic medication, working at referral level the study applied 
rigorous criterion to define high knowledge at reaching the score of 75% and above. Hence, 
75.3% (n=55) were knowledgeable, 12.3% (n=9) were having low knowledgeable and only 12.3 
%( n=9) were very knowledgeable. The mean score also showed that the knowledge level of 
participants was on average (64.33%, SD: 9.83%). These results are consistent with the findings 
bySodha, McLaughilin, Williams and Dhillon (2002:313) who found that 83% of nurse 
prescriber and 90% of non-prescriber had  poor to average knowledge in regard to medication 
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related issues. Three domain of antipsychotic medication were isolated to explore further 
participants’ knowledge of that particular matter. 
5.2.1 Nurses knowledge on therapeutic effects of antipsychotic medications 
 
One of the research questions addressed in this study was to determine nurses’ knowledge on 
antipsychotic therapeutic effects, nursing understanding of clinical values of antipsychotic 
medication as well as managing medication according patients’ needs and responses required 
knowledge base in psychopharmacology. The participants in the study by Manias and Bullock 
(2004:89) emphasized on the crucial nursing role of checking the effectiveness of medication on 
the symptoms presented by the patients. The findings of this study, revealed that the majority of 
nurses were very knowledgeable (45.2%, n=33) about therapeutic effects of antipsychotic 
medications followed by knowledgeable (43.8%, n=32) with only 11%, n=8 who had insufficient 
knowledge. The mean score of all participants was below (72.85%) the score considered as high 
with a score ranging from 18.52% and 100%. Similar results were found in the study by Ndosi 
and Newell(2009:378) who found variability in knowledge score between their participants with 
satisfactory answer on dosage and indication of medications.  
According to Aschenbrenner and Venable, (2009:40), nurses need to interrogate if the 
therapeutic effects of a given prescribed medication correspond to patients’ symptoms. Even 
though the majority of the participants in this study are knowledgeable, the minimum score is 
alarming (18.52%) as one person who scored such may be alone on duty and may not be able to 
ensure adequate drug administration. This was highlighted in a study by Armstrong-Ester et al. 
(2007:36) where nurse reported inappropriate reasons to administer the antipsychotic medication 
such as making patients content, facilitate nursing care or to reduce distress of the family. The 
results of this study suggest the improvement of participants’ knowledge on therapeutic effects. 
5.2.2 Nurses knowledge on antipsychotic medication name 
 
The mean score of knowledge on antipsychotic medication name was 81.91% (SD=16.88). 
Drawing from these findings, it is clear that nurses could correctly identify the antipsychotic 
medication name. Armstrong-Esther et al (2007:35) found inconsistent results in their study, 
where nurses were lacking knowledge about antipsychotic medication administered to old 
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people. They stressed that, monitoring of effectiveness and adverse effects entail knowledge of 
these medications. For this reason, during the whole process of medication management, they 
have to be sure of medication that patient receive in regard to the name.  
The nurses in this study were very knowledgeable (68.5%) and knowledgeable (28.8%) about 
antipsychotic medication they deal with in everyday practice. That means that they were not 
confused on what medication to order or to administer to the patient. However, Eisenhauer, 
Hurley and Dolan (2007: 86) stressed that medication knowledge transfer involve vigilance and 
critical thinking in order to endure that correct medication is given. Vogelsmeier,Scott-Cawiezell 
and Zellmer (2007:6) emphasized on good communication between the team members to ensure 
that accurate order, correct time and alleviating confusion between medications. In their study, 
Ellenbecker, Frazier and Verney (2004:168) found that nurses had difficulty in   recognizing 
medication as they found generic and brand names confusing. The 2.7% of nurses lacked 
knowledge of antipsychotic name and that may be linked to the confusion or  difficulties 
encountered in communicating with others in order to gain knowledge. 
5.2.3 Knowledge on antipsychotic adverse effects 
 
Antipsychotic medications are classified into two groups: old generation and new generation. In 
this study nurses were asked to identify the adverse effects pertaining of each group or shared by 
both. The difference of both classes are highlighted in the literature  by McEvoy, Zigman and 
Margolese(2010:145); Horacek et al. (2006:390) and Pandya(2009:24) who stressed that the first 
generation of antipsychotic act in blocking the receptors D2while the second generation act in 
blocking the receptor D2 and 5-HT2, therefore producing different therapeutic and adverse 
effects. 
In this study, the mean score of all nurses were 38.61% (SD=12.38). The majority of nurses 
67.1% (n=49) were inadequately knowledgeable as they scored under 50% for summed items. 
These results indicate knowledge deficit in regards to adverse effects of different antipsychotic 
classes. Similar finding were found in a study by Hemingway, Baxter, Smith, Burgess-Dawson 
and Dewhirst (2011:371) where 46% of nurses reported that their lack of knowledge on adverse 
effects of medication constituted a barrier in medication administration and by Manias and 
Bullock (2002:776)where nurses had insufficient knowledge on different groups of medications. 
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The lack of knowledge in the differentiation of adverse effects of classical and new generation of 
antipsychotic may be associated by the fact that at Ndera Neuro-psychiatric hospital they have a 
limited number of new antipsychotics as evidenced by their 2011 annual report  where they 
reported have only Risperdal in their stock (Hopital Neuro-Psychiatric Caraes Ndera, 2011:31). 
Adewuya et al (2006:210) found that  Nigerian patients were treated with old generation 
medication due to lack of alternative treatment. However, these findings are alarming as only 
32.9% are knowledgeable. The adverse effects of antipsychotic medication may be life 
threatening if not well monitored (Neuhut et al., 2009, Berman, 2011, Strauw et al., 2007), and 
may cause irrevocable symptoms (Pandya, 2009, Muench and Hamer, 2010) expose to metabolic 
(Newcomer and Haupt, 2006, Lambert et al., 2005, Osborn et al., 2008), cardiac (Koponen et al., 
2008, Healey, 2010) and other risks especially to some special groups such as old people (Panula 
et al., 2009, Knol et al., 2008), pregnant women (Galbally et al., 2010) and children ((Fritz, 2006, 
Self et al., 2010). 
The possible risks of antipsychotic medication must be discussed with patients openly and 
accurate information should be given (Jones and Jones, 2008:54). Moreover, the studies by King 
(2004:365); Manias and Bullock (2002:779), indicated that nurses knowledge on 
pharmacological theories are essential for monitoring adverse effects and identifying patients’ 
needshence, knowledge of adverse effects was perceived as crucial to nursing role. 
5.3 Knowledge on antipsychotic medication’ health education 
 
Participants were asked about their nursing practices in order to ensure patients’ compliance to 
antipsychotic medication and education to family and patients about medication they prescribed. 
The aim of these questions was to identify knowledge level of nurses working at Ndera Neuro-
Psychiatric hospital about monitoring practices of patients taking antipsychotic medication. 
The findings of this study revealed that nurses do have sufficient knowledge as the mean score 
was 79.50% (SD=20.20%). Studies by Sodha, McLaughlin, Williams and Dhillon (2002:313) 
have different results with poor knowledge of non-prescriber nurses about patients’ counselling, 
education in regard to medication. 
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Lan, Shiau and Lin (2003:372) maintained that monitoring of patients under antipsychotic 
medication requires cautiousness and knowledge especially when teaching patients about adverse 
effects as they may be reluctant to take medication. The results of this study are encouraging as 
65.8% (n=48) of participants are very knowledgeable and 27.4% (n=20) are knowledgeable. 
Though, past research has demonstrated that nurses did not dedicate enough time to deliver 
information to the patients (Kendall et al., 2007:176). In a study by Honey and Lim (2008:15) 
only 13% of the graduate nurses reported that they used their pharmacology knowledge patient 
monitoring. 
In this study, the responses ranged from 0-100%, the answers (strongly disagree, disagree and 
neutral) were rated as negative and scored as zero and few participants did not agreed or strongly 
agreed with all statements. This may be linked to hesitation or lack of confidence on behalf of 
our participants. Early studies  highlighted nurses’ lack of confidence in pharmacology related 
issues (Sodha et al., 2002:312). 
5.3.1 Nurses knowledge on monitoring patients’ compliance 
 
Participants in this study showed a very good level of knowledge in this regards as evidenced by 
the mean score of 83.75% and the highest score of 100%. These findings are inconsistent with 
the results of a  study by Manias and Bullock (2002:783)which found  that nurses, graduate 
nurses and experienced nurses  lacked pharmacological knowledge especially in pragmatic 
clinical situations. Also in a study by (Happell et al., 2002:254), the relevance to correlate  
surveillance of medication and patient life style was not perceived by nurses who worked in 
inpatient services. 
According to Janssen et al. (2006:234) nurses must adjust their treatment model to individual 
patient, prevent and monitor adverse effects, establish good relationship with patient, thus 
promote therapeutic alliance. Byrne et al (2005:517) found  that poor knowledge hinder nurses’ 
capacity to implement adherence strategies. The score on the level of knowledge on monitoring 
compliance also showed high knowledge as the majority (n=55, 75.3%) scored high marks. As 
the questions asked in this study were related to everyday practice about medication related 
issues and adherence promotion, we may be sure that the majority of nurses are aware of 
strategies to promote patients’ compliance. However, the asked question may not be exhaustive 
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and their knowledge may be related to the statements used for this study. Different strategies 
have been highlighted in literature such as rationalisation of the antipsychotic medication 
regimens (Rummel-Kluge et al., 2008: 386) motivational interviews (Drymalski and Campbell, 
2009:12) cognitive-behavioural therapy associated with psychosocial interventions (Patel et al., 
2010:273). All those strategies require nurses to possess a strong knowledge base in theoretical 
as well as practical psychopharmacology. It is stressed that the clinical effectiveness of 
antipsychotic medication can only be observed if patients remain on medication (Davies et al., 
2010: 103). Therefore, nurses must remember and update their knowledge on how to ensure that 
the medication they administer to the patient is taken. 
5.3.2 Knowledge on patient and family education practices 
 
From the conceptual point of view, education of patients and their family is at the centre of 
nursing role in management of medication and that requires knowledge on mediation and patient 
variables as well as interaction which occur between both parties (Aschenbrenner and Venable, 
2009:3). The results of this study suggest that nurses had good knowledge; the mean score was 
74.54% which is considered as average in this study. These results are consistent with others 
studies where nurses’ knowledge was good (Eisenhauer et al., 2007:85, Vogelsmeier et al., 
2007:10, Hemingway et al., 2011:373). However in most studies nurses’ knowledge about 
patient education was poor (Lim et al., 2010:104, Sodha et al., 2002:313, Ndosi and Newell, 
2009:577, Dilles et al., 2010:178). 
Patient and family education was perceived by nurses as a core responsibility in a study by 
Happell, Manias and Pinikahana (2002:254), especially with regards to information given about 
adverse effects and how medication could be managed in daily life. The research on psychosis 
also found that the family of the patient plays a vital role in patient functioning and urged to 
build and maintain relationships with them by giving information about symptoms and 
medication and providing emotional support (Uys and Middleton, 2004:386-387). It is clear that 
understanding of medication therapeutic actions and adverse effects contraindication and follow 
up will be at the base of accurate and valuable education. The results of this study are therefore 
promising as the majority of participants have a high level of knowledge about family and 
patient education (61.6%, n=45 very knowledgeable) and 26% (n=19), knowledgeable. 
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Although, nurses are knowledgeable about patient and family education the researcher is not  
sure of the transfer of this theoretical knowledge into practice. It was found that nurses working 
with inpatients found their environment particularly demanding with no time to dedicate to 
patient and family education even though they were aware of its importance (Happell et al., 
2002:255, Ellenbecker et al., 2004:166) and the study does not ignore that the lowest score in the 
study was 0% and 12.3% (n=9) of the participants had poor knowledge. 
5.4 Overall knowledge on antipsychotic medication management 
 
The results of this study suggest that participants had good knowledge on antipsychotic 
management as evidenced by the mean score of 68.4% (SD=11.53%). The findings are similar to 
that found in study done in the United Kingdom (Sodha et al.2002) to assess prescriber and non-
prescriber nurses’ confidence and pharmacological knowledge. The study found that the overall 
knowledge averaged 78% of prescribers and 71% of non-prescribers was at average level of 
knowledge. The average level was also found in Malaysia by Lexshimi,Daud &Zulkifli 
(2009:23). For this study, 65.8% were knowledgeable (average) and 24.7% were very 
knowledgeable. 
However, the level of knowledge in this study is higher than the level in previous studies. The 
results of the study by  Jones, Robson, Whitefield &Gray (2010:810) showed that only 48% of 
nurse prescribers had  acceptable knowledge. With regards to their responsibilities this was 
considered as inadequate knowledge. Insufficient pharmacological knowledge for nurses was 
found in a number of studies (King, 2004, Ndosi and Newell, 2009, Manias and Bullock, 2002, 
Simonsen et al., 2011). It was found that educational preparation for nurses in pharmacology was 
not sufficient enough to enable them to ensure their role (Manias and Bullock, 2002) and 
different authors suggested  the review of nursing curriculum (Manias and Bullock, 2002, 
Hughes, 2010) and continuing education (Carithers, 2011) in order to equip nurses with solid 




5.5 Association of respondents’ demographic variables and their knowledge 
 
The findings of this study found no difference in knowledge according to the age of the 
participants. This is inconsistent with the results of a study by Grendell-Niemi et al.(2005:690) 
who found that nurses  with more than 30 years of nursing experience were more knowledgeable 
than those with less nursing experience. In this study the group ranging between 26-35 years 
scored high median but there was no major gap with other groups. 
In this study, the experience in nursing profession and in hospital did not influence knowledge of 
the participants on antipsychotic medication. Similar results were found in the study by Lexshimi 
et al. (2009:23). However, other studies have shown that experience has a positive influence on 
nurses’ level of knowledge on pharmacology. Ndosi& Newell (2009:577) explored knowledge of 
nurses on medication they deal with on a daily basis and found  that nurses with more experience 
were very knowledgeable than the lesser experienced. Even though they were no statistically 
significant difference, the majority of nurses with high levels of knowledge had between 0-5 
years of experience while the group with experience between 6-10 years had a high number of 
medium knowledge (76%). These finding revealed unexpected results as the researcher assumed 
that nurses who manipulate medication every day for a given period may become familiar with 
how it works and the elements of surveillance about that medication.  
The antipsychotic medication may be classified in high alert medication as it demands nurses to 
be vigilant in patient safety and compliance. In a study on nurses’ knowledge on high alert 
medication, it was found that nurses with great experience were more knowledgeable of high 
alert medication and self-evaluation with regards to medication competencies. The results of this 
study may be due to the fact that many of the participants were less experienced at Ndera Neuro-
Psychiatric hospital 46.6% (0-5 years) and 34.2% (6-10 years). 
A link between qualification and knowledge on pharmacology has been established in the 
literature (Ndosi and Newell, 2009:577). The results of this study also revealed association 
between knowledge on antipsychotic medication and participant qualification (p=0.010). The 
participants with a bachelor’s degree scored high median (73.42) as well as advanced diploma in 
mental health nursing (72.15). This is also consistent with the results of the study by Sodha et al. 
(2002:314) who found  that high qualification lead to increased  knowledge and confidence in 
80 
 
pharmacology. However, in this study, the participant with a master’s degree scored low 
knowledge (29.11). This may be due to the fact that, the participant was new at Ndera Neuro-
psychiatric hospital as the masters qualification did not appear in the annual report for the year 
2010 (Ndera Neuro-Psychiatric hospital, 2011:57) and the mental health nursing may not be the 
speciality of this participant. Nevertheless, the researcher did not expect an advanced nurse 
practitioner to score low knowledge in psychopharmacology. The nurse auxiliary scored about 
the same as the highly qualified nurse (65.82). This may be due to the fact that there is no 
difference in job description in regard to medication management with their highly qualified 
counterparts. Similarly Dilles et al.(2010:178) found no difference between nurse assistants and 
registered nurses’ tasks. 
The findings for this study yield no association between training and knowledge on antipsychotic 
medication. Training in psychopharmacology is considered as a speciality area and it is 
emphasized on in training of mental health nursing at Kigali Health Institute. This curriculum 
seems to lack comprehensive and depth in the understanding of pharmacokinetic and 
pharmacodynamics  (Kigali Health Institute, 2007). According to the annual report Ndera 
hospital organize continuous education for  its employees via workshops, peer education and in 
service training (Hopital Neuro-Psychiatric Caraes Ndera, 2011). However, this was also not 
sufficient enough as there was one training session in a year for all the hospitals. 
This is consistent with previous studies (Manias and Bullock, 2002:782, Grandell-Niemi et al., 
2005:692) which  found that education preparation of nurses in pharmacology was insufficient.  
In service training and seminars have been recommended as a complementary method but not 
enough if isolated (Ito and Yamazumi, 2003:211, Manias and Bullock, 2002:780). This study 
suggests continuous and strong education and training in regard to psychopharmacology. 
5.6 Limitation of the study 
 
This study explored knowledge of nurses working at Ndera Neuro-Psychiatric hospitals that are 
responsible for antipsychotic medication management (ordering, prescribing, administering and 
monitoring) for inpatients. It is therefore hoped that this small exploratory study will contribute 
towards the field of nursing management and clinical practice particularly mental health.  
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However, some limitation was identified. The major limitations were derived from 
methodological issues. The sample size was determined using non-probability convenience 
sampling which is subject to bias and subjectivity (Polit and Beck, 2008:340). Hence, the sample 
cannot be assumed to be representative and therefore the results cannot be generalized to 
Rwanda. However, these results may contribute towards raising awareness on pharmacological 
knowledge gaps for nurses and serve as a basis of improvement and further investigations. 
The questionnaire used to gather data depended solely on self-report measures based mainly on 
Likert scale. Therefore, participants may be indisposed to disclose their state of mind and results 
may be based just on guessing. As the questionnaire was distributed at work, the participants’ 
responses could be influenced by external factors such as presence of a colleague who may 
mislead or simply by being there (Kothari, 2006:86). The instrument may also be complex to be 
understood by the respondents. To minimize such errors the questionnaire was reviewed by a 
panel of experts, and piloted and distributed during participants’ free time. In addition the 
instrument was adapted for two published instruments; even though pilot testing and reliability 
was done, further psychometric tests would be very useful. 
Nurses’ knowledge on psychopharmacology is a significant issue in inpatient settings as well as 
throughout health care system. Unfortunately, there is paucity of literature to base the 
interventions worldwide particularly in Africa. The actual literature used in this study emphasize 
on knowledge of antipsychotics in the elderly people; medication administration and errors. 
5.7 Recommendations 
 
The results of this study provide a good starting point for further research into the nurses 
knowledge on medication management in Rwanda  and its effects on patient safety, medication 
cost and quality care in general; as well as educational preparation for Rwandan nurses in regard 
to pharmacology. 
Nursing management interventions are recommended in order to increase knowledge 
consciousness. It is therefore crucial to establish a staff evaluation system and nurses should be 
offered  opportunities such as  self-assessment of their pharmacological performance and to 
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increase their knowledge. Nurse Managers are in best position and have legal responsibility to 
promote staff development with regards to competencies required in their job description; they 
should therefore assess nurses’ educational needs and provide an environment favourable to need 
satisfaction. Pharmacology learning forms part of continuous learning. Therefore, the 
management of institutions should provide organized and systematic continuous education in 
regards to antipsychotic medication management as well as other medications. This will ensure 
that staff achieves the desired level of knowledge. The nurses are also urged to be lifelong 
learners through self-assessment and updating their knowledge. 
In regard to clinical practice, nurses are in better position to ensure medication management and 
patient safety. Nurses must be aware that medication management is their responsibility and that 
they are accountable to patient safety and errors that occur during medication process. It is 
recommended to nurses to review and update knowledge of each medication they manipulate in 
order to avoid medication errors. The hospital could institute medication safety procedures, 
education and information protocols that can serve as knowledge base in medication 
management. 
Different studies have underlined inadequacies in pharmacological education. Nursing education 
training in both nursing schools and on job training opportunities should aim at addressing 
nurses’ lack of knowledge particularly mechanisms of action,  effectiveness, adverse effects 
,contraindications and interactions. Provision of adequate training on nursing role in patient and 
family education as well as the promotion of patients’ compliance is recommended. The actual 
curriculum should also be scrutinized and revised in order to alleviate knowledge gaps in 
providing breadth, depth pharmacological theoretical and practical knowledge. 
The results for this study suggest the need for further investigations to identify more precisely 
factors that influence nurse knowledge on psychopharmacology. The actual curriculum and 
nursing education need further studies in order to analyse if nurses are really prepared for their 
role in antipsychotic management. A qualitative study is recommended to analyse and 






The overall aim of this study was toexplore nurses’ knowledge of medication management 
specific to antipsychotic medication and factors associated with knowledge. As discussed the 
majority of at Ndera Neuro-Psychiatric hospital nurses are female, young in the nursing 
profession and with limited experience. Most nurses have an advanced degree in mental health 
nursing and have followed psychopharmacological training in academic institutions. Nurses 
showed high knowledge in regard to antipsychotic medication name; monitoring patients’ 
compliance and average knowledge on therapeutic effects and on patient and family education 
practices. However they scored very low on adverse effects, therefore, the results showed that 
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Appendix 1: Data collection instrument (English) 
Study title: Exploring nurses’ knowledge on the antipsychotic medication management in 
inpatient   psychiatric settings in Rwanda. 
 
Section A: Demographic data 
1. Gender 
Female                                                                   Male  
2. Age in years (number in years) 
25 year and fewer                                   26-35 years 
36- 45 years                                            46 years and more 
3. Experience as nurse 
0-5 years                     6- 10 years                     11- 20 years                  More than 20 years                   
4. Experience at Ndera Hospital 
0-5 years                     6- 10 years                     11- 20 years                  More than 20 years 
5. Qualification of participants  
Nurse auxiliary              Enrolled nurse                advanced diploma in mental health                  
Advanced diploma in general nursing                Bachelor                     Masters             
PhD   
 6. Training on psychopharmacology 






Section B: Knowledge on antipsychotic medication  
                                                                                    1=strongly disagree 
                                                                                    2=disagree 
                                                                                    3=neutral 
                                                                                    4=agree 
                                                                                    5= strongly agree 
 
7. What do you understand by antipsychotic medication?                   1 2 3 4 5 
1.The old generation has demonstrated effectiveness against positive 
symptoms 
    
2.The new generation of antipsychotic is the first line for treatment 
of psychosis 
    
3. All the first episode clients should have an antipsychotic free of at 
least 48 hours 
    
4. The new antipsychotic has demonstrated effectiveness against 
negative symptoms of psychosis 
    
5. The antipsychotic medication use start with low dose and increase 
gradually 
    
6. The antipsychotic medication are used in small dose in older 
people 
    
 
7. The antipsychotic medication has demonstrated effectiveness in 
treatment of delusions 
    
8. The patients experiencing hallucinations should be treated with 
antipsychotic medications 
    
9. Antipsychotic medication is effective to reduce aggressiveness      
10.Patients who have an initial dysphoric response to medication are 
more likely to stop medication 
    
11. Antipsychotics should be used to treat the abnormal behaviour in 
psychosis 
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12. Blockage of dopamine produce a reduction of hallucinations       
13. Blockage of dopamine produce a reduction of delusions       
14. Blockade of serotonin  5-HT2 produce a reduction of affective 
flattening 
    
15. Blockade of serotonin  5-HT2 produce a reduction of alogia and 
anhedonia 
    
16. They can have permanent side effects that affect the clients 
movement 
    
17. Patients taking chlorpromazine are susceptible to orthostatic 
hypotension 
    
18. They can result in increased risk of cardiovascular disease      
19. Antipsychotics rather than benzodiazepines should be used for 
sedation 
    
20.Antipsychotics should be given with careful caution during 
pregnancy 
    
21. Patients with epilepsies should be well monitored under 
antipsychotic medication 
    
22. Cardiovascular diseases may constitute a contraindication of 
antipsychotic medications 
    
23. The precautions should be taken to prescribe an antipsychotic 
medication to patients with diabetes 
    
24. Special attention should be paid to old people and children under 
antipsychotic medication 
    
25. Alcohol must be avoided  with an antipsychotic medication      
 
26. The antipsychotic should  decrease effectiveness if given with 
anticonvulsants 
    
27. The antidepressants should be given with precautions to patients 
under antipsychotic medication 





8. Is the following an antipsychotic drugs? Yes Non Don’t know 
1.Haloperidol    
2.Levopromazine    
3.Chlorpromazine    
4.Risperidone     
5.Zuclopentixol    
6.Flupentixol    
7.Pimozide     
8.Olanzapine    
9.Sulpiride     
10.Pericyazine    
 
9. Indicate with a tick the side effect that result from first generation, second generation or 
if from both then tick both 
Side effects / adverse effects First generation Second generation 































11.Muscle spasms or cramps* 
 
  
12. Tremors, * 
 
  












*: Fist generation **: Second generation *** : Both    
Section C: Nursing role  
                                                                                    1=strongly disagree 
                                                                                    2=disagree agree 
                                                                                    3=neutral 
                                                                                    4=agree 
                                                                                    5= strongly agree 
 
10. Do you think the following statements meet 
the patients’ medication compliance 
promotion? 
1 2 3 4 5 
1.Discussing with patient what they think is wrong 
with them 
     
2.Assessing patients’ history of illness      
3.Assessing physical health      
4.Discussing with patients their worries or 
concerns about illness 
     
5.Discussing with patients the link between 
disruptions in their life and the need to take 




6.Discussing with the patient the good and not so 
good things about medication 
     
7.Asking patients what they expect from 
medication  
     
8.Asking patients what they expect from  care 
giver 
     
9.Discussing with patient the meaning medication 
has to them 
     
10.Having a written agreement with the patient 
about taking medication 
     
11.Giving to medication to the patient      
12. Checking to see if  the patients has adverse 
effects 
     
13. Checking and measure the vital signs  
( BP , Pulse, Temperature, )of the patients 
     
14. Engaging with the patient in the counselling 
around medication compliance issues 
     
 
11. Do you think the following statements meet 
the patients and family education on psychotic 
medication? 
1 2 3 4 5 




    
2.Discuss with patient the way medication works      
3.Discussing with the patient confusion between 
symptoms and adverse effects 
     
4.Discussing the adverse effects with the patients      
5.Discuss the adverse effect with the family of the 
patient 
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6.Discussing with the family the way medication 
works 
     
7.Giving patient written information regarding the 
medication they are prescribed 
     
8.Giving the families of the patient written 
information about medication 
     
9.Undertaking group education about medication 
with patients and families 
     
10.Giving the patient information about treatment 
strategies (hospitalization, day or night therapy 
,psychotherapy, psycho-education, and type of 
drugs( oral, IM,IV, long acting) 
 
 
    
11. Giving the patient the choice about medication  
 
    
12. Giving the patient and families information 
about available services ( Eg: referral services, 

















Appendix 2:  Data collection instrument (French) 
 
Titre d’étude : Exploring nurses’ knowledge on the antipsychotic medication management in 
inpatient   psychiatric settings in Rwanda. 
Section A: Données démographiques 
1. Genre 
FémininMasculin 
2. Age en année  (nombre d’années) 
25 ans et moins                                     26-35 ans 
36- 45 ans                                           46 ans et plus 
3. Experience commeinfirmier(e) 
0-5 ans                          6- 10 ans                       11- 20 ans                        Plus de 20 ans 
 
4. Expérience à l’hôpital de Ndera  
0-5 ans                           6- 10 ans                        11- 20ans                     Plus de 20 ans 
 
5. Qualification professionnelle du participant 
Auxiliaire                    Infirmière A2                   A1 en santé mentale                              
A1 en science infirmière                  Licence                Maitrise                    Doctorat 
 
 7. Formation en pharmacologie 
Université/Ecole              Séminaires              Education par les pairs                  







Section B: Connaissances sur les médicaments antipsychotiques  
                                                                                    1=Fortement d’accord 
                                                                                    2=D’accord 
                                                                                    3=neutre 
                                                                                    4=En désaccord 
5= Fortement en désaccord 
 
7. Que comprenez-vous par  médicaments antipsychotiques                   
 
1 2 3 4 5 
1. Les antipsychotiques classiques ont démontré leur efficacité 
contre les symptômes positifs 
    
2. La nouvelle génération antipsychotique est le traitement de choix 
pour les psychoses 
    
3. Pour tous les premiers épisodes psychotiques, les patients doit être 
observes au moins 48 heures sans traitement antipsychotique 
    
4. Les nouveaux antipsychotiques ont démontré leur efficacité contre 
les symptômes négatifs 
    
5. L’usage des antipsychotiques commence par une dose minimale et 
augmente graduellement 
    
6. Les antipsychotiques sont utilisés à de petite doses chez les gens 
âgés 
    
 
7. Les médicaments antipsychotiques ont démontré l’efficacité 
contre les délires 
    
8. Les patients souffrant des hallucinations peuvent être traité par les 
médicaments antipsychotiques 
    
9. Les médicaments antipsychotiques  sont efficaces pour réduire 
l’agressivité 
    
10. Un patient qui répond initialement par l’humeur dysphorique au 
traitement antipsychotique est plus susceptible d’arrêter les 
médicaments 
    
11. Les médicaments antipsychotiques peuvent être utilisés pour 
traiter un comportement désorganisé 
    
12. Blocage de la dopamine produit une réduction des hallucinations      
13. Blocage de la dopamine produit une  réduction des délires       
14. Blocage de la sérotonine 5-HT2 produit une réduction de l’affect 
émoussée 
    
15. Blocage de la sérotonine  5-HT2 produit une réduction d’alogie     
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et de l’anhédonie 
16. Ils ont les effets secondaires permanents qui affectent les 
mouvements du client 
    
17. Les patients sous chlorpromazine sont susceptibles d’une 
hypotension orthostatique 
    
18. Les antipsychotiques augmentent le risque des maladies 
cardiovasculaires 
    
19. Les antipsychotiques plutôt que les benzodiazépines  doivent être 
utilisés pour la sédation 
    
20. Les antipsychotiques doivent être utilisés avec précautions 
pendant la grossesse 
    
21. Les patients avec épilepsies sous traitement antipsychotique 
doivent être bien contrôlés 
    
22. Les maladies cardiovasculaires peuvent constituées une contre-
indication des médicaments antipsychotiques 
     
23. Les médicaments antipsychotiques sont prescrits avec 
précautions chez les patients souffrant du diabète 
    
24. Les enfants sous traitement antipsychotiques méritent une 
attention spéciale 
    
25. Alcool doit être évité avec un traitement antipsychotique      
26. L’efficacité des antipsychotiques est réduite si administrésé avec 
les  anticonvulsivants 
    
27. Les antidépresseurs doivent être donnés avec précautions chez 
les patients sous antipsychotiques 




8. Les médicaments suivants sont-ils antipsychotiques? Oui Non Je ne sais 
pas 
1.Haloperidol    
2.Levopromazine    
3.Chlorpromazine    
4.Risperidone     
5.Zuclopentixol    
6.Flupentixol    
7.Pimozide     
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8.Olanzapine    
9.Sulpiride      




9. Indiquer ou cocher les effets secondaires qui  résultent de la première génération, 





1.Bouche sèche   
2. Vision floue   
3. Vertiges   
4. Gain pondéral   
5.Constipation                                             
6. Agitation   
7. Tristesse   
8. Arrythmiecardiaque   
9. Hypotension   
10.Hyperprolactnemie   
11. Crampe et spasmemusculaire   
12.  Tremblement   
13. Dyskinesie tardive       
14. Agranulocytose   
15. Hyperglycemie   
16. Hyperlipidemie   
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Section C: Nursing role  
                                                                                    1=Fortement d’accord 
                                                                                    2=D’accord 
                                                                                    3=neutre 
                                                                                    4=En désaccord 
5= Fortement en désaccord 
 
10. Quel est le rôle infirmier dans la gestion des 
médicaments antipsychotiques? 
1 2 3 4 5 
1. Discuter avec le patient de ce qu’il pense de ses 
problèmes 
     
2. Discuter avec le patient de son histoire      
3. Evaluer l’histoire de la maladie du patient      
4. Evaluer l’état de la santé physique      
5. Discuter avec les patients de leurs inquiétudes et 
préoccupations sur la maladie 
     
6. Discuter avec le patient sur le lien entre les 
perturbations dues à la maladie et la nécessité de 
prendre les médicaments 
     
7. Discuter avec le patient  les effets bénéfiques et 
les effets secondaires des médicaments 
     
8. Demander aux patients ce qu’ils attendent des 
médicaments et des soignants 
     
9. Discuter avec le patient  ce que le médicament 
signifie pour lui 
     
10. Avoir le consentement écrit sur la prise des 
médicaments 
     
11. Administrer les médicaments aux patients      
12. Vérifier pour voir si le patient n’a pas des effets 
secondaires 
     
13. Contrôler et mesurer les signes vitaux du 
patient 
     
14.  Engager le counselling avec le patient autour 
des médicaments et de la compliance 






11. Pensez-vous que les déclarations suivantes 
rencontrer les patients et l'éducation familiale 
sur les médicaments antipsychotiques? 
 
1 2 3 4 5 




    
2. Discuter avec le patient le médicament manière 
dont fonctionne 
     
3. Discuter avec les patients la confusion entre les 
symptômes et les effets indésirables 
     
4. Discuter les effets secondaires avec les patients      
5. Discuter les effets secondaires avec la famille du 
patient 
     
6. Discuter avec la famille la manière dont les 
médicaments fonctionnent 
     
7. Fournir aux patients des informations écrites 
concernant les médicaments dont ils sont prescrits 
     
8. Fournir aux familles de l'information écrite sur 
les médicaments des patients 
     
9. Entreprendre avec les familles l'éducation 
groupale sur les médicaments 
     
10. Fournir aux patients l'information sur les 
stratégies de traitement (hospitalisation, thérapie du 
jour ou nuit, psychothérapie, psychoéducation et le 
type de médicaments (oral,IM,IV,retard) 
 
 
    
11 Donner au patient le choix sur les médicaments  
 
    
12. Donner l'information des patients et des 
familles sur les services disponibles 
 
 










Appendix 3: Information document (English) 
 
Study title: Exploring nurses’ knowledge on the antipsychotic medication management in 
inpatient psychiatric settings in Rwanda. 
Dear nurse, 
I am GASANGANWA Marie Claire students in Master’s Program in nursing management at 
University of KwaZulu-Natal. I am currently conducting a research thesis entitled: Exploring 
nurses’ knowledge on the use of antipsychotic medication at Ndera Neuropsychiatric hospital, 
Rwanda. 
I would very much appreciate your participation in this research study. I will not ask your name 
so the information you provide will be anonymous and confidential. The findings of this study 
will be used to identify knowledge gaps, training needs and to plan accordingly. As you have 
been selected to be part of my study sample, the questionnaire to be completed will help to 
collect data needed for this study. 
Your participation in this study is voluntary and you will be free to withdraw from the study at 
any time if you no longer wish to participate in the study without consequence. Your consent to 
participate in this study will be confirmed by completing the questionnaire. 
If you have any question or concerns regarding this research project please feel free to contact 
me at gasanganwa@yahoo.fr or you may contact my supervisor Mrs Shangase Nondumiso at 
shangasen@ukzn.ac.za. 








Appendix 4 : Information document (French) 
 
Titre d’étude : Explorer les connaissances des infirmières sur la gestion des médicaments 
antipsychotiques en milieu hospitalier psychiatrique au Rwanda. 
Cher  infirmiers (ères), 
Je suis Gasanganwa Marie Claire, étudiante en maitrise, gestion des soins infirmiers à 
l’Université de Kwa-Zulu Natal. Actuellement, pour ma thèse, j’ai entrepris une étude intitulée 
“Exploration de la connaissance des infirmiers (ères) sur l’utilisation des médicaments 
antipsychotiques à l’hôpital Neuropsychiatrique de Ndera, Kigali-Rwanda” 
Je vous serais très reconnaissante pour votre participation à cette étude. Nous ne vous 
demandons pas vos noms et les informations fournies resteront anonyme et confidentielles. Les 
résultats de cette étude seront utilisés pour identifier les lacunes des connaissances, identifier les 
besoins en formation et de planifier en conséquences. Si vous avez choisi de participer à cette 
étude, le questionnaire qui doit être rempli nous aidera à rassembler les données nécessaires à 
cette étude. 
Votre participation est volontaire et vous serez libre de se retirer à tout moment que vous voulez 
sans conséquences. Votre consentement à participer à cette étude sera confirmé en remplissant le 
questionnaire. Si vous avez des questions ou des préoccupations concernant ce projet de 
recherche s’il vous plaît n’hésitez pas à me contacter à gasanganwa@yahoo.fr  ou contacter mon 
superviseur Madame Nondumiso Shangase à shangasen@ukzn.ac.za. 
 







Appendix 5: Informed consent and declaration of consent (English) 
 
Consent to participate in research 
Study title: Exploring nurses’ knowledge on the antipsychotic medication management in 
inpatient   psychiatric settings in Rwanda. 
 
Dear Nurse 
You have been asked to participate in a research study. You have been informed about the study 
by GASANGANWA Marie Claire having read the information document which has the details 
of this study. You may contact on gasanganwa@yahoo.fr. Tel: +250788459195, +27833635747 
at any time if you have questions about the research. You may also contact my supervisor on 
shangasen@ukzn.ac.za or Tel: +27312602855. 
Your participation in this research is voluntary, and you will not be penalized or lose benefits if 
you refuse to participate or decide to stop. If you agree to participate in this study, you will sign 
below this document in the space provided as a show of your declaration consent. 
Declaration of consent 
I.................................................................................... (Full names of participant) hereby confirm 
that I understand the contents of this document and the nature of the research project and I agree 
to participate voluntary in this research project. I understand that I am at liberty to withdraw 
from the project at any time, should I so desire. 
………………………………….                                                    ………………………… 
Signature of participant                                                                 Date                  
 
......................................................                                                   ....................................... 
Signature of researcher 
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Appendix 6 : Le consentement éclairé et de la déclaration de consentement  
1. Consentement à participer à la recherche 
Titre de l'étude: Explorer les connaissances des infirmières sur la gestion des médicaments 
antipsychotiques en milieu hospitalier psychiatrique au Rwanda. 
Chers infirmiers(ères) 
Vous avez été invité à participer à une étude de recherche. Vous avez été informé de l'étude 
menée par Marie Claire GASANGANWA avoir lu le document d'information qui a les détails de 
cette étude. Vous pouvez contacter le chercheur sur  gasanganwa@yahoo.fr , 
Tél:+250788459195,  +27833635747, à tout moment si vous avez des questions concernant la 
recherche. Vous pouvez également communiquer avec mon superviseur sur 
shangasen@ukzn.ac.za,  ou Tel: 27312602855. 
Votre participation à cette recherche est volontaire, et vous ne serez pas pénalisé ou perdre des 
avantages si vous refusez de participer ou de décider d'arrêter. Si vous acceptez de participer à 
cette étude, vous allez signer ce document ci-dessous dans l'espace prévu comme une 
démonstration de votre déclaration  au consentement. 
 
2. Déclaration de consentement 
 
Moi, ................................................ ................................... (Nom et prénom du participant) 
confirme par la présente que je comprends le contenu de ce document et la nature du projet de 
recherche et je suis d'accord pour participer volontaire dans ce projet de recherche. Je comprends 
que je suis à la liberté de se retirer du projet à tout moment, dois-je le désire. 
 
Signature du participant ………………………………………….Date 
  





Appendix 7: Request of permission to conduct the researchat Ndera Neuro-
Psychiatrichospital 
Director General                                                                                 27th June, 2011                                                     
Ndera Neuro-psychiatric hospital,    
Kigali / Rwanda 
 
Reverend Brother: 
Application to conduct a research at Ndera Neuro-psychiatric hospital 
I hereby request permission to conduct research at Ndera Neuro-Psychiatric hospital.  
I am a student at the University of KwaZulu-Natal in the School of Nursing, undertaking a 
Master degree in Nursing Management. One of the requirements for the degree is to conduct a 
research project. 
The title of the research is “Exploring nurses’ knowledge on the antipsychotic medication 
management in inpatient   psychiatric settings in Rwanda” 
Ndera Neuro- Psychiatric hospital was purposively chosen to be the setting for this study. Data 
will be collected from 82 nurses  working at Ndera hospital. Nurses will be required to complete 
one questionnaire and this will take place during break time. This protocol will be submitted to 
the Research Ethics Committee of the University of KwaZulu-Natal, for approval. It is also being 
submitted to the Research and Ethics committee of KHI for approval. These approvals will be 
forwarded to you as soon as they are available. Also attached is the informed consent for 
participants which shows that participation is voluntary and how the rights and identity of the 
patients will be protected in the research process.  





Appendix 8: Letter of request for application for approbation 
Marie Claire Gasanganwa                                                                              30th Jun, 2011       
 
The Executive Secretary                                                                                 
KHI  Research Comittee,    
Kigali -Rwanda 
Dear Sir: 
Application for approbation of a research proposal  
I hereby request the approbation of my research proposal by KHI.  I am a student at the 
University of KwaZulu-Natal in the School of Nursing, undertaking a Master degree in Nursing 
Management. One of the requirements for the degree is to conduct a research project  
The title of the research is “Exploring nurses’ knowledge on the antipsychotic medication 
management in inpatient   psychiatric settings in Rwanda” 
Ndera Neuro- Psychiatric hospital was purposively chosen to be the setting for this study. Data 
will be collected from 82 nurses who are working at Ndera hospital. Nurses will be required to 
complete one questionnaire and this will take place during break time. This protocol will be 
submitted to the Research Ethics Committee of the University of KwaZulu-Natal, for approval. 
This letter will be forwarded to you as soon as it is available.  
The research protocol, the data collection tools and the consent form for participants are enclosed 
herein. 
Your consideration will be greatly appreciated. 
Yours faithfully 
Marie Claire GASANGANWA 
Research Supervisor: Mrs NONDUMISO Shangase (University of KwaZulu-Natal) 
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Appendix 12: Permission to use questionnaire  
Précédent | Aller au message Suivant Ajouter un drapeau à ce mail 
Re: Questionnaire! 
Samedi 14 mai 2011 10h34 
De:  
"mbyrne@uow.edu.au" <mbyrne@uow.edu.au> 
Afficher les détails du contact 
À:  
"Marie Claire GASANGANWA" <gasanganwa@yahoo.fr> 
Sure. You have my permission  
Dr. Mitchell Byrne 
Clinical and Forensic Psychologist 
Senior Lecturer 
 
From: Marie Claire GASANGANWA <gasanganwa@yahoo.fr> 
Date: Sat, 14 May 2011 17:59:39 +1000 



















Précédent | Aller au message Suivant | Retour aux messages 
Marquercomme non lu(s) | Imprimer   
 
 
 Ajouter un drapeau à ce mail 
Re: Instruments 
Mardi 5 Juillet 2011 14h53 
De:  
"Christine Smith" <SmithC5@cardiff.ac.uk> 
Ajouterl'expéditeurdans les contacts 
À:  
"Marie Claire GASANGANWA" <gasanganwa@yahoo.fr> 
Dear Maria 
 
Thank you for your email regarding your MSc studies.  
 
 You are welcome to use the questionnaire that was used in the pilot study- Nurses knowledge in the use of anti 
psychotic medication and older people.  Please ensure that its referenced in your work and in any future 
publications.   
 
I can send you an electronic copy if you would like that?  
 
Best wishes in your studies 
 
Regards 





From:        Marie Claire GASANGANWA <gasanganwa@yahoo.fr> 
To:        Christine Smith <smithc5@cf.ac.uk> 
Date:        05/07/2011 10:05 








Appendix 14: Proof reading 
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